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of draft genome annotation originally generated in the absence of transcript coverage data, and provides new
insights into organismal biology and regulatory mechanisms. This dissertation provides an extensive analysis
of mRNA-seq data from the obligate intracellular protozoan parasite Toxoplasma gondii, a ubiquitous
pathogen of humans and other vertebrates. We produced and sequenced 24 strand-specific RNA libraries
from several parasite strains and developmental stages, and examined these in con�junction with 45
additional mRNA-seq libraries produced by other groups.
The current reference genome annotation for T. gondii, generated using de novo methods informed by cDNA
sequencing prior to mRNA-seq, identifies ~8300 protein-coding genes, fragmented by ~40K introns.
Untranslated regions are incompletely defined, few alternatively-spliced transcripts are described, and non-
coding transcripts remain largely unexplored. mRNA-seq datasets presented in this dissertation define a total
of 2.7M introns, most observed at vanishingly low abundance. Using current annotation to define parameters
minimizing false discovery yields ~60K likely splice junctions. Comparing the frequency of intron-spanning
reads to the abundance of transcripts to which introns belong provides a reliable metric for estimating intron
excision, readily distinguishing introns that are (i) universally used, (ii) alternatively-spliced, or (iii) likely
insignificant. Genome-wide analysis suggests ~3000 annotated introns that should be deleted from the
reference genome, ~1400 to be added as alternative isoforms, ~3100 as additions to existing annotation (often
within UTRs) and ~3400 associated with novel transcripts. Transcriptomic expression is consis�tent with
biological and phenotypic variation across the complex parasite life cycle, including undescribed differences in
gene expression during intracellular tachyzoite replication. Strong circumstantial evidence also suggests that
lncRNAs may play an important role in regulating stage-specific expression during sexual differentia�tion and
sporogony. These results provide the basis for revising the reference T. gondii genome annotation available at
ToxoDB.org and GenBank. Strategies developed in this dissertation also provide the basis for defining
annotation criteria for other species, including related parasites responsible for malaria and conceivably other
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ABSTRACT 
 
TRANSCRIPT DIVERSITY IN THE PROTOZOAN PARASITE TOXOPLASMA GONDII 
 
María Alejandra Díaz-Miranda 
David S Roos 
Technological advances have made possible to sequence RNA transcripts at 
unprecedented depth, enabling deep profiling of abundance and diversity under a variety 
of conditions.  Such information permits refinement of draft genome annotation originally 
generated in the absence of transcript coverage data, and provides new insights into 
organismal biology and regulatory mechanisms.  This dissertation provides an extensive 
analysis of mRNA-seq data from the obligate intracellular protozoan parasite 
Toxoplasma gondii, a ubiquitous pathogen of humans and other vertebrates.  We 
produced and sequenced 24 strand-specific RNA libraries from several parasite strains 
and developmental stages, and examined these in conjunction with 45 additional mRNA-
seq libraries produced by other groups. 
 The current reference genome annotation for T. gondii, generated using de novo 
methods informed by cDNA sequencing prior to mRNA-seq, identifies ~8300 protein-
coding genes, fragmented by ~40K introns.  Untranslated regions are incompletely 
defined, few alternatively-spliced transcripts are described, and non-coding transcripts 
remain largely unexplored.  mRNA-seq datasets presented in this dissertation define a 
total of 2.7M introns, most observed at vanishingly low abundance.  Using current 
annotation to define parameters minimizing false discovery yields ~60K likely splice 
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junctions.  Comparing the frequency of intron-spanning reads to the abundance of 
transcripts to which introns belong provides a reliable metric for estimating intron 
excision, readily distinguishing introns that are (i) universally used, (ii) alternatively-
spliced, or (iii) likely insignificant.  Genome-wide analysis suggests ~3000 annotated 
introns that should be deleted from the reference genome, ~1400 to be added as 
alternative isoforms, ~3100 as additions to existing annotation (often within UTRs) and 
~3400 associated with novel transcripts.  Transcriptomic expression is consistent with 
biological and phenotypic variation across the complex parasite life cycle, including 
undescribed differences in gene expression during intracellular tachyzoite replication.  
Strong circumstantial evidence also suggests that lncRNAs may play an important role in 
regulating stage-specific expression during sexual differentiation and sporogony.  These 
results provide the basis for revising the reference T. gondii genome annotation 
available at ToxoDB.org and GenBank.  Strategies developed in this dissertation also 
provide the basis for defining annotation criteria for other species, including related 
parasites responsible for malaria and conceivably other eukaryotes as well.   
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CHAPTER 1:  INTRODUCTION & OVERVIEW 
	
The promise of genomics to improve understanding of biology 
It has been known for decades that much of the genetic potential of organisms, as 
encoded in their DNA, is put into practice through the action of proteins, which carry out 
a wide variety of structural and biochemical functions.  This critical conversion is medi-
ated by DNA transcription into messenger RNA (mRNA), and mRNA translation into 
protein … the ‘Central Dogma’ of molecular biology.  More recently, we have come to 
appreciate that RNA molecules can also carry out a wide variety of regulatory functions, 
including the modulation of transcription, translation, and mRNA stability (Turner and 
Morris 2010; Raina and Ibba 2014; Radhakrishnan and Green 2016). 
New technologies for nucleic acid library construction and sequencing allow us to 
profile the entire repertoire of organismal transcriptomes, under a variety of conditions, 
making it possible to improve our understanding of organismal biology by analyzing the 
abundance of mRNA and other RNA molecules.  Technological developments have also 
made it possible to conduct similarly comprehensive analysis of other genomic datasets: 
chromatin modifications, protein composition, etc.  The high degree of resolution made 
possible by these techniques reveals many previously unrecognized RNAs, posing a 
challenge: how to interpret this vast wealth of information?  What is biologically meaning-
ful, and what is meaningless noise? 
The goal of this dissertation is to develop methods for extracting maximal informa-
tion from modern transcriptomic datasets.  How can we exploit mRNA transcriptomes to 
better define gene structures?  What is the diversity of other RNA molecules?  What 
role(s) do these RNAs play in regulating gene expression? 
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My dissertation research focuses on the protozoan parasite Toxoplasma gondii, an 
experimentally accessible human pathogen.  Because T. gondii displays many of the 
molecular features observed in other eukaryotic species, it is likely that these methods 
will be broadly applicable to other organisms as well. 
Eukaryotic gene expression 
While the central dogma of molecular biology outlines the flow of information from 
DNA to RNA to protein, there are many twists to this basic story.  For example, many 
RNAs – snRNAs, rRNA, tRNAs, and other small and long non-coding RNAs – are never 
translated into proteins.  Instead, they perform biological functions by interacting with or 
recruiting protein complexes for specific functions.  Because RNA is typically single 
stranded, it can fold onto itself by base-pairing complementary nucleotides within its 
sequence to create complex three-dimensional shapes capable of performing structural 
and catalytic functions (Li, Zheng, Ryvkin, et al. 2012; Li, Zheng, Vandivier, et al. 2012; 
Incarnato and Oliviero 2016).  Modern genomic scale projects have revealed that up to 
three quarters of the human genome is transcribed in one or more cells … but only half 
of these transcripts appear to have protein coding potential (Djebali et al. 2012; Harrow 
et al. 2012).  Which of these transcripts play functional roles remains an open question. 
Understanding transcript expression patterns, how gene expression is regulated, and the 
biological significance of previously uncharacterized transcripts, is likely to help us 
understand how cells and organisms alter their behavior in response to external signals. 
One common mechanism of transcriptional gene regulation in eukaryotes involves 
trans-acting proteins that recognize and bind to cis regulatory sequences in DNA 
(promoters), typically upstream of the transcription start site.  For example, eukaryotic 
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promoters often include a short sequence of T and A nucleotides ~25 nucleotides 
upstream of the transcription initiation site, that is bound by the TATA-binding protein.  
When transcription factors bind to a promoter, they recruit and/or modulate the activity of 
RNA polymerase on DNA (Todeschini, Georges, and Veitia 2014).  After being brought 
to the promoter region by transcription factors, RNA polymerase starts synthesizing 
short fragments of RNA until it undergoes a conformational change, brought about by 
transcription factor-mediated phosphorylation of its C-terminal domain, thereby 
strengthening binding to DNA and forcing transcription factor dissociation (Wong, Jin, 
and Struhl 2014; Bowman and Kelly 2014).  Cooperation between RNA polymerase and 
other proteins helps to initiate transcription.  For example, activator proteins recognize 
DNA regulatory regions (enhancers), usually upstream of promoters, helping to recruit 
transcriptional machinery to the transcriptional start site via mediator proteins that 
communicate with the polymerase, favoring transcription (Plaschka et al. 2015). 
Other biological structures may also affect transcription, including the histone com-
plexes that help to organize the extremely long DNA molecules of eukaryotic chromo-
somes.  Nucleosomal positioning with respect to promoters may impact transcription, as 
does how tightly DNA is wrapped around the nucleosome, which is determined by 
histone modifications (Gissot et al. 2007; Croken, Nardelli, and Kim 2013).  Histone 
methylation, acetylation, and other modifications may block polymerase access 
(Todeschini, Georges, and Veitia 2014) or other components of the transcriptional 
machinery. 
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Transcript processing 
Some non-coding RNAs are known to recruit chromatin-remodeling proteins to 
specific regions of the genome, modulating the addition of active or repressive marks 
onto histones (Rinn et al. 2007; Chu et al. 2015) and could also regulate the accessibility 
of the transcription machinery.  Once transcription starts, elongation factors associate 
with the RNA polymerase and allow it to transcribe for long distances without dissociat-
ing from the DNA. 
In eukaryotes, primary transcripts are typically processed co-transcriptionally, at the 
same time that RNA polymerase synthetizes the new transcript.  This is possible thanks 
to the ability of RNA polymerase to change conformations after phosphorylation of its C-
terminal domain, exposing other binding sites for multiple proteins that modify the struc-
ture of the RNA transcript as it is transcribed.  Major modifications to RNA transcripts 
include the addition of a 5’ ‘cap’, addition of polyadenine nucleotides in its 3’ tail and 
removal of intervening sequences (introns) by the spliceosomal machinery.  Terminal 
modifications act as protective measures providing transcript stability until translation is 
set to occur, and may be recognized by the translational machinery. 
In contrast, intron excision affects the sequence of the mature mRNA, and often 
how it is translated into protein.  The spliceosome, formed by small nuclear ribonucleo-
proteins (snRNPs) and auxiliary factors, recognizes specific dinucleotide sequences 
upstream and downstream of introns (donor and acceptor splice sites), as well as a 
branch site within intron boundaries, and it performs two trans-esterification reactions 
between the recognized sequences to excise introns from mRNA transcripts.  
Spliceosome recognition specificity drives alternative splicing of introns, choosing from 
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among the various combinations of strong and weak donor and acceptor splice sites 
within a transcriptional unit (Kornblihtt et al. 2013), providing yet another level of 
regulation that may yield mature mRNA variants (Wang et al. 2008). 
Alternative splicing, based on differential use of splice donors and/or acceptors, 
may alter exon boundaries, include or exclude exons (exon skipping), or read through 
introns (intron retention).  Because differential splicing affects internal mRNA nucleotide 
sequences, it may also affect sequence in any resulting translation products, particularly 
as nucleotide sequences are read in sets of three during translation into protein, so the 
addition or subtraction of nucleotides may shift the reading frame, altering all down-
stream protein coding. 
Mature mRNA transcripts may also be regulated at various levels, including RNA 
turnover mediated by degrading enzymes (Houseley and Tollervey 2009), and export 
from the nucleus where mRNAs are formed to the cytoplasm where translation occurs.  
Finally, it is also important to note that functional gene expression is also regulated at 
the level of protein translation and stability.  Because of the relative ease of RNA trans-
cript analysis using modern molecular biological techniques, however, steady-state 
transcript abundance is commonly used as surrogate for measuring functional gene 
expression. 
Eukaryotic genomics, in the era of new sequencing technologies 
Although the importance of DNA and RNA in protein production has been under-
stood for more than 50 years, until the advent of high-throughput sequencing methods, 
this process could only be studied at the level of individual genes, mRNA, or proteins.  
Modern nucleic acid sequencing technologies make it possible to sequence billions of 
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nucleotides per day, enabling complete genome sequencing for essentially any organ-
ism, even for eukaryotes, whose genomes range from ~107-1011 bp. 
The sequencing depth reached with modern sequencing technologies gives a near-
complete snapshot of transcriptomes with a much higher dynamic range of expression 
levels and at a base-pair level resolution, in contrast to microarray technologies.  How-
ever, the increase in depth in several NGS technologies, such as Illumina, SOLiD and 
454, is possible thanks to the short length of reads that are sequenced (35-500bp). Short 
reads are assembled back into full-length transcripts by either de novo assembly, based 
on a reference genome (ab initio assembly) or with a combined approach merging these 
two strategies.  The assembly process is not trivial, as it requires large memories in 
computing systems to assemble large quantities of short reads and also the ability to 
correctly assign sequencing reads to specific variants of the same transcript in the case 
of de novo assembly.  Sequencing reads from both ends of cDNA fragments (100-250bp 
– paired end protocol) and joining the overlapping reads to form a longer read can help 
solve the problem posed by short reads.  This strategy, however, will not solve assembly 
difficulties if the paired end reads don’t overlap.  An even better approach to avoid 
assembly problems is to sequence single RNA molecules or large fragments of near-
complete cDNAs, as proposed by Helicos and Pacific Biosciences technologies.  These 
technologies also have PCR amplification-free protocols, which usually results in better 
sequencing coverage of high GC regions, although their sequencing error rates are 
higher than those from short read technologies.  An ideal strategy to study the transcript-
ome would be to combine sequencing results from different technologies as each of 
them have advantages and difficulties (Martin and Wang 2011) 
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The exploration of gene function and expression often begins with analysis of DNA 
sequence elements, along with attempts to define the most probable gene structure 
within a DNA sequence.  Ab initio gene finders rely on recognizing structural features on 
genes that are extracted from the genomic sequence alone.  Prokaryotic genome analy-
sis is now relatively straightforward, for a variety of reasons.  In addition to their relatively 
small genome size (typically 106-107 bp), prokaryotic promoter sequences are often 
highly conserved, enabling systematic identification.  Further, the lack of intervening 
sequences fragmenting protein coding genes enables protein products to be predicted 
by simple translation of long open reading frames (ORFs) using the universal genetic 
code).  In contrast, the promoters and regulatory sequences for most eukaryotic genes 
cannot currently be defined by specific sequence motifs.  And splicing of primary mRNA 
transcripts produces protein coding regions or exons that are joined by non-coding 
regions or introns, greatly complicating prediction of complete coding sequences. 
Sequencing technology may also be used to determine mRNA sequences after first 
converting RNA to DNA via the action of reverse transcriptase, and from the outset has 
been used to sequence individual clones mRNAs, or fragments of randomly-selected 
mRNAs (expressed sequence tags; ESTs).  Because transcript abundance can differ by 
several orders of magnitude, however, comprehensive cataloging of transcripts initially 
relied upon hybridization to arrays constructed based on synthetic oligonucleotides, 
manufactured based on ab initio predictions of gene sequences.  While immensely valu-
able for assessing gene-level transcript abundance, such methods are compromised by 
the inaccuracy of ab initio gene predictions, and usually unable to distinguish between 
alternatively-spliced transcripts. 
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With the continued increase in sequencing capacity (and decline in cost), it has 
recently become possible to consider sequencing at sufficient depth to effectively profile 
essentially all of RNAs in a cell or tissue.  This strategy offers several advantages over 
array-based expression profiling.  Because it does not depend on the accuracy of gene 
model predictions, it provides an assumption-free method for identifying transcripts, 
regardless of the polymerase used, transcript processing, or their potential to encode 
proteins.  Further, deep sequencing permits identification of alternative transcription 
products from the same gene.  Mapping mature mRNAs back to the reference genome 
provides direct evidence of alternative transcript initiation, termination, and/or splicing, 
providing the basis for improved gene-finding algorithms (de novo predictions), guided 
by mRNA sequences and other lines of evidence (DNA accessibility based on histone 
positioning, chromatin modification or nuclease sensitivity; transcription factor binding; 
etc).  Methods have also been devised to address other concerns, such as the use of 
ribosomal profiling to identify transcripts that are actually loaded onto ribosomes, rather 
than steady-state mRNA levels that fail to take into consideration such important factors 
as transcript translatability or stability. 
Integration of additional extrinsic features into gene finder algorithms permits better 
definition of gene models, including identification of alternatively spliced transcripts, 
definition of non-coding regions within genes or UTRs and identification of previously 
unannotated genes, including non-coding RNA transcripts.  The challenge raised by this 
wealth of data, however, is how to distinguish between biologically important results, and 
rare events unlikely to manifest themselves in any significant way.  For example, the first 
ab initio annotation of the human genome predicted approximately 30 thousand genes, 
but pilot projects designed to explore and annotate transcript diversity in detail suggests 
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up two 200 thousand distinct transcripts (Djebali et al. 2012; Harrow et al. 2012).  Are 
these all functionally significant?  The goal of this thesis is to exploit a model eukaryotic 
system, the protozoan parasite Toxoplasma gondii, to develop methods for improving 
the accuracy of genome annotation as well as applying this knowledge to enhance our 
understanding of organismal biology. 
Biology of the protozoan parasite Toxoplasma gondii 
Toxoplasma gondii is a unicellular eukaryotic parasite with interesting and clinically 
important biology.  This species’ developmental cycle encompasses both sexual and 
asexual stages, in distinct environments (Figure 1), presumably requiring distinct pat-
terns of gene expression.  Asexual T. gondii ‘tachyzoites’ are haploid obligate intracellu-
lar parasites, capable of invading any nucleated cell, in any warm-blooded vertebrate.  
Within the infected cell, tachyzoites establish a specialized ‘parasitophorous vacuole’ 
within which they replicate clonally, doubling every 8-16 hours until they lyse the infected 
cell 2-3 days later, releasing new tachyzoites that can infect neighboring cells.  All 
pathogenesis by T. gondii (and the many thousands of other parasites in the phylum 
Apicomplexa) is directly attributable to rapid proliferation.  Toxoplasmosis in humans is 
characterized by tissue damage, retinal degeneration, encephalitis, etc.  In the absence 
of an effective immune response, the consequences can be fatal. 
Tachyzoites are highly promiscuous, and readily able to cross epithelial barriers, 
including the blood/brain barrier and the placenta.  During pregnancy, a primary infection 
in the mother can be transmitted to the developing fetus, leading to fetal abortion or 
severe congenital abnormalities.  The underdeveloped immune system of the fetus is 
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unable to recognize and efficiently attack the rapidly dividing tachyzoites, leading to 
extensive tissue destruction. 
In healthy adults, the immune system typically eliminates tachyzoites, but a subset 
of parasites differentiate into a slowly replicating ‘bradyzoite’ form that is poorly recog-
nized by the immune system, and which can persist within specialized tissues cysts for 
the life of the host.  Latent bradyzoite cysts periodically recrudesce to produce acutely 
lytic tachyzoites, providing a natural boost to the anti-T. gondii immune response … but 
also threatening immunocompromised individuals, including HIV/AIDS sufferers, or 
patients immunosuppressed for cancer chemotherapy or transplantation.  Bradyzoite 
tissue cysts are particularly common in muscle tissues and the central nervous system, 
probably because they are able to persist in these locations for long periods of time as 
the immune response ramps up.  Carnivory is probably the most common source of 
human infection, as bradyzoite cysts can be transmitted by ingestion of infected tissues. 
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Figure 1.  The complex development life cycle of the protozoan parasite Toxoplasma 
gondii.   
Humans and other vertebrates become infected with T. gondii through the ingestion (or injection) 
of oocysts from the environment (contaminated soil or water) or tissue cysts from contaminated 
meat.  Excystation is triggered by the acidic environment of the stomach, leading to the emerg-
ence of sporozoites or bradyzoites within the small intestine.  These motile forms infect the intes-
tinal epithelium and differentiate to form tachyzoites, which replicate rapidly, ultimately lysing the 
infected cell and invading neighboring cells and tissues throughout the body.  This lytic cycle can 
continue indefinitely, and is responsible for all parasite pathogenesis.  A small fraction of tachyzo-
ites differentiate into tissue cysts, perhaps in response to immune attack, containing slow-growing 
bradyzoites, enclosed within a thin proteoglycan wall impervious to immune attack.  Within the 
intestinal epithelium of felines (only), parasites undergo sexual differentiation to produce micro- 
and macro-gametes, which fuse to produce an oocyst that is released into the intestinal lumen 
and excreted in the feces.  Upon exposure to oxygen and ambient temperature in the environ-
ment, these diploid oocysts undergo rapid meiotic reduction to produce haploid sporozoites. 
 
The sexual stages of T. gondii only develop in feline intestinal epithelium, typically 
after ingestion of an infected mouse.  Why sexual development doesn’t occur in other 
	
12	
	
animals is unknown, but is typical of the phylum Apicomplexa.  For example, Neospora 
parasites can also infect many species, but only replicate sexually in dogs.  The Plasmo-
dium parasites that cause malaria only undergo sexual differentiation in anopheline 
mosquitoes.  In the feline intestinal epithelium, Toxoplasma tachyzoites differentiate into 
micro- and macro-gametocytes (analogous to sperm and eggs), and fuse to produce 
diploid oocysts that are shed in cat’s feces.  Upon exposure to ambient oxygen, meiotic 
reduction produces four haploid sporozoites, still encapsulated within the oocyst wall, but 
ready to start a new asexual cycle when the sporulated oocyst is ingested by the next 
host via contaminated soil or water.  Sporulated oocysts remain viable in the 
environment for decades. 
Once ingested by an uninfected (immunologically naive) host, bradyzoite tissue 
cysts or sporulated oocysts excyst in the gut, initiating a new round of invasion and 
asexual replication and completing the parasite life cycle.  The ability to be transmitted 
via contaminated water or food (meat harboring bradyzoite tissue cysts, or vegetables 
grown in contaminated soil) probably accounts for the ubiquitous nature of this parasite.  
Approximately one third of the global human population is estimated to be infected with 
this parasite (Blader et al. 2015). 
Although Toxoplasma is a diploid organism, capable of sexual reproduction, note 
that only haploid forms replicate.  As a consequence, the successful progeny of sexual 
recombination (in cats) yields clonal parasites capable of rapid proliferation.  The 
population biology of T. gondii is characterized by such clonal rockets, transmitted either 
via carnivory, or through selfing in cats (individual T. gondii zoites are totipotent, able to 
produce both micro- and macro-gametes).  For example, while virtually all parasite 
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isolates show some evidence of relatively recent sexual recombination, most isolated 
from North America and Europe belong to just a few closely-related lineages (Howe and 
Sibley 1995; Khan et al. 2011; Lorenzi et al. 2016). 
Experimental accessibility of Toxoplasma gondii 
Consistent with their promiscuous nature, tachyzoite parasites can be cultivated 
indefinitely in vitro, in either transformed cell lines (HeLa, CHO, LM, MDBK, Vero, 3T3, 
etc) or primary cells (foreskin fibroblasts, astrocytes, macrophages, etc).  Various stress 
treatments (oxidative stress, alkali shock, etc) can be used to induce bradyzoite differen-
tiation in vitro.  Moreover, infection of mice provides an in vivo model that closely mimics 
human disease.  Sexual differentiation has not been reproducibly observed in vitro, but 
experimental infection of cats is a reliable (but expensive) method for carrying out tradi-
tional genetic crosses.  The resulting progeny display typical Mendelian inheritance: four 
haploid sporozoites are produced from a diploid oocyst after meiotic division 
(Pfefferkorn, Pfefferkorn, and Colby, 1977; Dubey, Lindsay, and Speer 1998).  Because 
only haploid forms replicate (see above), it is not possible to assess heterozygote 
phenotypes, but this limitation can be partially addressed by molecular genetic 
manipulation (see below). 
An extensive experimental toolkit is available for exploring T. gondii molecular and 
cellular biology, including transfection vectors, strategies for insertional mutagenesis, 
selectable markers, conditional and inducible expression, knockout and gene manipula-
tion systems (including the CRISPR technology), localization of organelles and/or genes 
by tagging with fluorescent probes, etc (Donald and Roos 1993; Sibley, Messina, and 
Niesman 1994; Roos et al. 1995; Soldati 1996; Belperron et al. 2001; Bradley, Li, and 
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Boothroyd 2004; Gubbels et al. 2008; Huynh and Carruthers 2009; Fox et al. 2009; Fox 
et al. 2011; Andenmatten et al. 2013; Rommereim et al. 2013; Sidik et al. 2016).  
Moreover, as a member of the protozoan phylum apicomplexan, including many other 
parasites of clinical and economic significance (Plasmodium species are responsible for 
malaria, Cryptosporidium is a leading cause of diarrheal disease in infants, Eimeria is 
the leading infectious disease concern in the poultry industry, Babesia, Neospora and 
Theileria are important cattle pathogens, etc), many of the experimental tools and 
insights gleaned from Toxoplasma have proved to be applicable to other parasites.  For 
example, transfection systems developed for Toxoplasma provided the basis for trans-
fection of Plasmodium, and insights into mechanisms of drug resistance, the process of 
cell invasion, the biology of the apicoplast (see below) and some aspects of host-
parasite interactions have proved to be of general interest (Kim and Weiss 2004; Blader 
et al. 2015; McFadden and Yeh 2017). 
Toxoplasma gondii cell and molecular biology 
Toxoplasma harbors a typical complement of eukaryotic organelles, including a 
typical eukaryotic nucleus, cytoskeletal elements, complex endomembrane system, and 
mitochondria.  Some organelles present distinctive features, however.  For example, in 
contrast to the open mitosis observed in metazoan systems, the nuclear envelope 
remains intact throughout mitosis (closed mitosis, as observed in most unicellular 
eukaryotes).  The nuclear envelope plays an important role in chromosome segregation, 
as it organizes the centrosome, mitotic spindle, and chromosomal centromeres to form 
the centrocone (Brooks et al. 2011; Farrell and Gubbels 2014).  Toxoplasma also har-
bors various apicomplexan specific organelles, including the apicoplast (a non-
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photosynthetic plastid acquired by secondary endosymbiosis of a eukaryotic alga, and 
retained as an essential organelle; (Köhler et al. 1997; Ralph et al. 2004), apical 
secretory organelles (micronemes and rhoptries), and the apical polar ring and conoid 
(Graindorge et al. 2016).  These organelles constitute the apical complex, for which the 
phylum Apicomplexa is named.  Secretory organelles play distinct roles in key aspects of 
the life cycle, including host cell attachment, invasion and egress (Besteiro et al. 2009; 
Huynh, Boulanger, and Carruthers 2014; Roiko, Svezhova, and Carruthers 2014; Huynh 
and Carruthers 2016), establishment and maintenance of the parasitophorous vacuole, 
and intracellular survival and interaction with the host cell (Saeij et al. 2007; Fentress et 
al. 2010; Reese et al. 2011; Fentress et al. 2012; Fleckenstein et al. 2012; Fox et al. 
2016; Leroux et al. 2015). 
At ~ 65 Mb (14 chromosomes), the Toxoplasma DNA genome is significantly 
smaller than animal, plant, and many other parasite genomes, but much larger than 
prokaryotic genomes.  Genes are not arranged in operons, as in prokaryotic microbes, 
and transcription is mediated by typical eukaryotic polymerases and part of the basal 
transcriptional machinery, recruited by some conserved general transcription factors 
(TFIID, E, F, H, etc), under the influence of promoters, enhancers and chromatin marks 
similar to those found in other eukaryotes (Meissner and Soldati 2005; Sullivan et al. 
2013).  Apicomplexan transcription factors are dominated by AP2-integrase domain-
containing proteins (Balaji et al. 2005), which are among the 20 most abundant Pfam 
domains in tissue-cyst forming coccidian parasites like T. gondii (Lorenzi et al. 2016).  
Primary T. gondii mRNAs are capped and polyadenylated – although there is also 
evidence of non-polyadenylated transcripts – and contain numerous cis-introns, but no 
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known trans-splicing.  Introns are excised using standard eukaryotic spliceosomal 
machinery, as human nuclear extracts can properly splice T. gondii primary transcripts, 
and vice versa.  These features are important for both ab initio and de novo gene 
finders, as well-characterized human splice signals can be incorporated as intrinsic 
features during gene detection. 
Toxoplasma genes were first cloned in the 1980s and sequencing of random 
expressed sequence tags (ESTs) in the 1990s defined several thousand additional 
genes expressed in tachyzoite parasites (Ajioka et al. 1998).  Northern blotting, qPCR 
and analysis of EST frequency provided the first glimpse of transcript abundance, 
including identification of related transcripts suggesting alternative splicing (Donald et al. 
1996; Chaudhary et al. 2005).  
A first draft of the T. gondii reference genome completed in 2002 (shortly after 
completion of the human genome sequence) and assembled EST clusters mapped to 
the genome defined many gene models used to train ab initio and de novo gene finders 
predicting a total of approximately 8000 genes with protein coding potential.  With the 
availability of annotated gene models, microarrays were designed to assess the trans-
criptional levels for all predicted genes (Bahl et al. 2010).  This platform has been used 
by the global T. gondii research community to define stage- and strain-specific gene 
expression (see ToxoDB.org; Kissinger et al. 2003).  As noted above, however, assess-
ment of expression levels in microarray experiments poses several limitations.  Back-
ground fluorescence signal corrections, typically excludes analysis of weakly expressed 
transcripts.  Furthermore, since probe design is restricted to correct gene number esti-
mation and requires preexisting knowledge of gene structure, microarray technology is 
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not well-suited to identifying errors in the present gene annotation, alternative trans-
cripts, or unannotated genes.  In contrast, RNA-seq technologies are able to profile all 
transcripts.  These characteristics render RNA-seq technology suitable for evaluating 
transcriptome expression and improving the quality and accuracy of genome annotation. 
Overview of this dissertation 
By enabling comprehensive interrogation of organismal genomes, genomic-scale 
datasets are becoming an increasingly important tool in biological and biomedical 
research.  This wealth of information holds promise for improved genome analysis, and 
new insights into the molecular mechanisms of many biological processes.  The abund-
ance of data also creates a serious challenge:  How to better identify and interpret 
relevant information from these datasets?  How do we discriminate biological signifi-
cance and incorporate this information into decision-making?  More specifically, is my 
gene-of-interest expressed?  Is it correctly annotated, in all its forms? 
The goal of this thesis is to develop analytic methods that permit discrimination of 
significance among genome-scale datasets, particularly transcriptome data derived from 
RNA-seq experiments.  In pursuit of this goal, we have focused on the genome of Toxo-
plasma gondii, comparing current gene annotation to transcriptional evidence derived 
from RNA-seq experiments across all life cycle stages in order to identify errors in gene 
annotation, unannotated genes, and alternatively spliced transcripts.  
As briefly described above, T. gondii is a unicellular eukaryotic parasite capable of 
causing disease in immunocompromised humans and animals, and a well studied 
organism, with a near complete genome sequence and a myriad of experimental tools. 
We constructed and sequenced 24 strand-specific RNA-seq libraries intended to explore 
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transcriptional variation across the intracellular lytic tachyzoite stage of the life cycle, and 
examined these together with 45 additional sequenced libraries profiling transcription in 
other life cycle stages.  All of these datasets are now available on line at ToxoDB.org, 
and deposition in GEO is in progress. 
These datasets have been used, in conjunction with other functional genomic infor-
mation where appropriate, to explore the feasibility of identifying stage-specific markers 
based on transcriptional profiling data, and to improve the status of genome annotation, 
including untranslated regions, previously unrecognized exons and alternatively spliced 
transcripts, and novel transcripts, including long non-coding RNAs (lncRNAs).  Through-
out this dissertation research, I have attempted to emphasize methods that should be 
broadly applicable to other eukaryotic microbes for which similar datasets are available. 
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CHAPTER 2:  USING SEQUENCING TECHNOLOGIES (AND OTHER LARGE-SCALE 
DATASETS) TO ASSESS AND IMPROVE GENOME ANNOTATION IN 
TOXOPLASMA GONDII (Adapted From Paper) 
 
New sequencing technologies have made many species accessible to genomic-
scale analysis, raising the challenge of how to integrate such information from various 
sources, discriminate biological significance, and make these results accessible to 
diverse end-user communities.  We have exploited strand-specific RNA-seq analysis to 
profile the transcriptome of human host cells infected with the protozoan parasite Toxo-
plasma gondii, a prominent eukaryotic microbial pathogen responsible for disease during 
congenital infection and in immunosuppressed individuals (Tenter, Heckeroth, and 
Weiss 2000). 
At ~65 Mb in length, the T. gondii genome is relatively compact (Lorenzi et al. 
2016), but harbors most of the complexity described for other eukaryotic genomes, 
including ~8300 protein coding genes, ranging in length from <1 to >60 kb (ave ~4.8 kb), 
and fragmented by introns (range 0-60+; ave ~5.8) that follow consensus eukaryotic 
sequence constraints (primary T. gondii transcripts are properly spliced by human 
nuclear extracts).  Extensive population genetic and functional genomic datasets are 
available for T. gondii, including additional RNA-seq data and other transcriptional 
profiles for various strains and developmental stages, proteomics data, chromatin marks, 
etc (ToxoDB.org; Gajria et al. 2008).  As noted above (Chapter 1), numerous tools are 
also available for experimental manipulation of T. gondii in the laboratory (Roos et al. 
1995; Sibley et al. 2002; Kim and Weiss 2004; Meissner et al. 2007; Sidik et al. 2016).  
We have generated strand-specific RNA-seq datasets for various T. gondii tachyzoite 
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strains, at multiple time points during their 48 hr intracellular in vitro replicative cycle, and 
analyzed these in parallel with datasets from other life cycle stages, to assess the 
accuracy of current genome annotation, identify new genes (including alternatively 
spliced transcripts), and assess stage-specific transcript expression and regulation 
(Chapter 3). 
Methods 
Parasite cultures, RNA isolation, RNA library construction and sequencing 
T. gondii tachyzoites from four different strains (ME49, VEG, RH, GT1), were main-
tained by serial passage in human foreskin fibroblast (HFF) monolayers as previously 
described (Roos et al. 1995), infecting confluent monolayers with ~107 tachyzoites. For 
time course experiments, parasites were propagated in Vero cells (Cercopithecus aethi-
ops) for two passages immediately before the infection of HFFs for RNA isolation, to 
avoid inadvertent contamination with human material from the previous infectious cycle.  
After media removal, cell monolayers were scraped in 700ul of Qiazol, and RNA isolated 
from cell lysates using the Qiagen miRNEasy mini kit, according to the manufacturer's 
instructions.  Six biological replicates were collected per strain and timepoint, and 
checked for RNA quality using a BioAnalyzer (Agilent).  Strain M4 bradyzoites, strain 
CZ-H3 enterocytes (gametocytes), and strain M4 oocysts were prepared and RNA 
isolated as previously described (Buchholz et al. 2011; Fritz, Buchholz, et al. 2012; 
Juránková et al. 2013; Basso et al. 2013; Hehl et al. 2015).  Biological replicates were 
pooled, and total and polyA+ selected RNA used to construct strand-specific mRNA (and 
in some cases small non-coding RNA) libraries as previously described (Li, Zheng, 
Vandivier, et al. 2012; Elliott et al. 2013), and sequenced on Illumina Hi-Seq 2000 (see 
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Table 1 for total number of reads per library).  All RNA-seq data described in this study 
are available from the Toxoplasma Genome Database, at ToxoDB.org (Gajria et al. 
2008), along with other RNA-seq datasets and diverse additional information (Fritz, 
Bowyer, et al. 2012; Minot et al. 2012; Reid et al. 2012; Lorenzi et al. 2016). 
Alignment of RNA-seq reads to the T. gondii genome: the ToxoDB pipeline for 
mapping RNA-seq reads 
For transcript assembly, RNA-seq reads were initially mapped onto T. gondii ME49 
genome release 28 using RUM (Grant et al. 2011); subsequent studies used GSNAP 
(Wu and Nacu 2010) to map to genome version 29.  The RUM alignment pipeline takes 
advantage of the speed of Bowtie (Langmead et al. 2009) to map against both the gen-
ome and transcriptome; unmapped reads are then mapped against the genome using 
Blat (Kent 2002), and Information from all three mappings is then merged.  GSNAP was 
configured to look for both known and novel splicing.  Coverage was determined for 
unique and non-unique alignments (separated by strand when possible).  Strand orienta-
tion of splicing was determined based on the usage of GT/AG, GC/AG, or AT/AC dinuc-
leotide pairs on the plus strand (or their complements on the minus strand).  In cases 
where strand could not be defined, the program applies a probabilistic splice model to 
determine orientation (Wu and Nacu 2010).  Performance for both RUM and GSNAP 
tools is comparable to the best RNA-seq alignment tools available at the time this study 
was completed (Engström et al. 2013). 
Algorithm for gene model learning and prediction 
Gene model training and predictions were performed using a version of CRAIG (A. 
Bernal et al. 2007) that integrates RNA-seq data, encoded as features derived from the 
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mapping of reads to the T. gondii genome, as described above.  The evidence integra-
tion strategy and feature encoding for RNA-seq data have been reported previously 
(Bernal, Crammer, and Pereira 2012; Bernal and Pereira 2012).  ToxoDB v28 gene 
annotations were used for training, after filtering to exclude genes with evidence of 
significant alternative splicing (see below).  The learned model integrates ab initio feat-
ures such as segment length distributions, with features derived from junction-spanning 
and coverage reads.  We sought completeness in transcript prediction by forcing CRAIG 
to define at least one transcript model for each non-overlapping transcript junction (puta-
tive intron) with read counts >3, and for overlapping junctions, those displaying >20% of 
the highest support observed in any overlapping junction within the same gene model. 
Assessment of genome annotation, analysis of alternative splicing and visualiza-
tion 
To assess the quality of the reference T. gondii genome annotation, constructed 
largely based on ab initio methods informed by EST sequences from tachyzoite stage 
parasites only, expression data was retrieved for all predicted introns in 69 RNA-seq 
samples available in ToxoDB.org (Table 1), including samples from many strains, and 
most T. gondii life cycle stages (see Chapter 1 for a description of the parasite’s asexual 
and sexual life cycles).  This yielded a list of 2,731,523 candidate introns, but many were 
observed in only one or two samples, or at very low abundance levels in any sample.  
Introns observed <6 times overall, or with <3 read in any of the 69 samples considered, 
were excluded from further analysis, leaving a total of 147,715 for in-depth analysis 
(including 997 previously-annotated introns not satisfying the above criteria). 
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Table	1.		List	of	T.	gondii	RNAseq	datasets		used	in	this	study	(ToxoDB	release	28)
Ref Strain Stage Host Cond Time RNA Str	Spec Ins	Size Read	Ln Total	Reads	* Tg	Unique	* %	† Total	ISRs	‡ %
Intracellular	Tachyzoites	--	Diverse	Strains
GT1	Sibley 1			 1 GT1 TachyzoiteHFF	cells In	vitro 72	hr? polyA+ No unknown 100+100? 164,728,174				 28,962,965						 17.6% 2,630,466								 9.1%
ME49	Sibley 2			 1 ME49 " " " " " " unknown 100? 31,824,251						 22,950,642						 72.1% 2,726,503								 11.9%
ARI 3			 2 ARI TachyzoiteHFF	cells In	vitro 72	hr? polyA+ No 220 40+40	 127,295,324				 20,890,634						 16.4% 1,607,718								 7.7%
B41 4			 2 B41 " " " " " " " " 39,158,742						 7,627,165									 19.5% 465,197											 6.1%
B73 5			 2 B73 " " " " " " " " 27,010,286						 6,775,092									 25.1% 446,632											 6.6%
BOF 6			 2 BOF " " " " " " " " 31,918,787						 8,692,004									 27.2% 593,508											 6.8%
CAST 7			 2 CAST " " " " " " " " 30,684,829						 12,688,027						 41.3% 772,439											 6.1%
CASTELLS 8			 2 CASTELLS " " " " " " " " 25,943,434						 11,269,884						 43.4% 698,953											 6.2%
CEPdelta 9			 2 CEPdelta " " " " " " " " 22,911,358						 9,730,742									 42.5% 646,186											 6.6%
COUGAR 10	 2 COUGAR " " " " " " " " 26,336,254						 10,043,346						 38.1% 630,228											 6.3%
DEG 11	 2 DEG " " " " " " " " 24,488,338						 13,221,779						 54.0% 791,392											 6.0%
FOU 12	 2 FOU " " " " " " " " 27,511,865						 4,801,559									 17.5% 345,916											 7.2%
GPHT 13	 2 GPHT " " " " " " " " 17,408,230						 4,098,107									 23.5% 298,438											 7.3%
GT1 14	 2 GT1 " " " " " " " " 30,487,790						 11,530,934						 44.2% 919,285											 6.8%
GUYDOS 15	 2 GUYDOS " " " " " " " " 27,575,023						 13,468,205						 85.4% 765,443											 3.3%
GUYKOE 16	 2 GUYKOE " " " " " " " " 45,820,315						 23,550,991						 51.4% 1,347,240								 5.7%
GUYMAT 17	 2 GUYMAT " " " " " " " " 26,315,451						 9,347,030									 35.5% 600,355											 6.4%
MAS 18	 2 MAS " " " " " " " " 19,686,294						 10,123,378						 51.4% 611,495											 6.0%
ME49 19	 2 ME49 " " " " " " " " 25,200,682						 11,045,627						 43.8% 653,377											 5.9%
P89 20	 2 P89 " " " " " " " " 27,368,978						 16,818,388						 61.5% 1,034,813								 6.2%
PRUdelta 21	 2 PRUdelta " " " " " " " " 35,047,626						 19,656,333						 56.1% 1,140,965								 5.8%
RAY 22	 2 RAY " " " " " " " " 23,593,872						 9,785,081									 41.5% 616,145											 6.3%
Rhdelta 23	 2 Rhdelta " " " " " " " " 61,603,537						 29,353,242						 47.6% 1,824,046								 6.2%
ROD 24	 2 ROD " " " " " " " " 45,907,606						 16,795,259						 36.6% 1,315,830								 7.8%
RUB 25	 2 RUB " " " " " " " " 44,678,085						 17,164,186						 38.4% 1,114,844								 6.5%
TgCATBr44 26	 2 TgCATBr44 " " " " " " " " 51,063,437						 17,750,373						 34.8% 1,118,740								 6.3%
TgCATBr5 27	 2 TgCATBr5 " " " " " " " " 22,403,348						 6,857,924									 30.6% 413,230											 6.0%
TgCATBr9 28	 2 TgCATBr9 " " " " " " " " 63,264,704						 17,443,532						 27.6% 1,372,374								 7.9%
VAND 29	 2 VAND " " " " " " " " 41,694,538						 28,878,303						 69.3% 1,846,138								 6.4%
VEG 30	 2 VEG " " " " " " " " 18,166,749						 9,144,480									 50.3% 598,049											 6.5%
WTD3 31	 2 WTD3 " " " " " " " " 34,270,722						 14,811,235						 43.2% 937,868											 6.3%
Intracellular	Tachyzoites	--	Developmental	Series
Reid	D3 32	 3 VEG TachyzoiteHFF	cells In	vitro 72	hr polyA+ No 200-250 76+76 65,238,810						 51,911,446						 79.6% 4,096,024								 7.9%
Reid	D4 33	 3 " " " " 96	hr " " " " 77,988,674						 63,623,584						 81.6% 5,170,913								 8.1%
RH	2	hr 34	 4 RH TachyzoiteHFF	cells In	vitro 		2	hr polyA+ Yes 275-375	 100 1,894,365									 194,671												 10.3% 35,875													 18.4%
RH	22	hr 35	 4 " " " " 22	hr " " " " 14,927,266						 8,930,207									 59.8% 1,605,429								 18.0%
RH	36	hr 36	 4 " " " " 36	hr " " " " 16,839,750						 15,348,364						 91.1% 2,209,144								 14.4%
GT1	2hr 37	 4 GT1 TachyzoiteHFF	cells In	vitro 		2	hr " " 275-375	 " 3,918,897									 364,309												 9.3% 64,074													 17.6%
GT1	4hr 38	 4 " " " " 		4	hr " " " " 833,498												 111,155												 13.3% 23,529													 21.2%
GT1	8hr 39	 4 " " " " 		8	hr	 " " " " 2,453,961									 514,210												 21.0% 99,994													 19.4%
GT1	16hr 40	 4 " " " " 16	hr " " 275-375	 " 59,500,308						 21,584,941						 36.3% 3,712,516								 17.2%
ME49	2hr 41	 4 ME49 TachyzoiteHFF	cells In	vitro 		2	hr " " 55-150 " 60,290														 4,250																 7.0% 480																		 11.3%
ME49	4hr 42	 4 ME49 TachyzoiteHFF	cells In	vitro 		4	hr " " " " 59,182,474						 5,850,571									 9.9% 523,097											 8.9%
ME49	8hr 43	 4 " " " " 		8	hr	 " " " " 42,147,632						 5,833,363									 13.8% 479,805											 8.2%
ME49	16hr 44	 4 " " " " 16	hr " " " " 19,467,179						 4,387,649									 22.5% 403,446											 9.2%
ME49	36hr 45	 4 " " " " 36	hr " " 275-375	 " 19,313,474						 10,951,950						 56.7% 1,763,689								 16.1%
ME49	44hr 46	 4 " " " " 44	hr " " " " 13,648,696						 12,332,981						 90.4% 1,722,462								 14.0%
VEG	2	hr 47	 4 VEG TachyzoiteHFF	cells In	vitro 		2	hr " " 55-150 " 116,612,403				 13,005,698						 11.2% 1,088,000								 8.4%
VEG	4	hr 48	 4 " " " " 		4	hr " " " " 58,188,707						 7,680,123									 13.2% 661,484											 8.6%
VEG	8	hr 49	 4 " " " " 		8	hr	 " " " " 57,496,732						 9,139,881									 15.9% 742,082											 8.1%
VEG	16	hr 50	 4 " " " " 16	hr " " " " 26,968,837						 6,543,629									 24.3% 665,172											 10.2%
VEG	36	hr 51	 4 " " " " 36	hr " " 275-375	 " 22,772,838						 12,418,256						 54.5% 2,058,765								 16.6%
VEG	44	hr 52	 4 " " " " 44	hr " " " " 14,768,871						 8,826,301									 59.8% 1,369,143								 15.5%
Bradyzoite	development
Knoll	acute	mouse 53	 5 ME49 TachyzoiteHFF	cells In	vitro 10	days polyA+ No unknown 50+50? 619,510,492				 868,532												 0.1% 51,040													 5.9%
Knoll	chronic	mouse 54	 5 " Bradyzoite Mouse In	vivo 28	days " " " " 662,065,868				 1,441,169									 0.2% 100,103											 6.9%
InVitro	Bz 55	 9 ME49 BradyzoiteHFF	cells In	vitro 		7	days polyA+ Yes 55-150 50 29,120,884						 26,411,628						 90.7% 2,098,534								 7.9%
InVivo	Bz 56	 8 M4 Bradyzoite Mouse In	vivo 21	days " " 275-375 100 113,123,601				 27,297,107						 24.1% 4,452,108								 16.3%
Gametocyte	development
Hehl	Tz 57	 9 CZ-H3 TachyzoiteHFF	cells In	vitro control polyA+ Yes unknown 100+100? 199,141,200				 85,515,887						 42.9% 10,548,750					 12.3%
Hehl	D3 58	 9 " GametocyteCat	intestinal	epitheliumIn	vivo 		3	days " " " " 552,571,698				 12,947,597						 2.3% 1,719,245								 13.3%
Hehl	D5 59	 9 " Gametocyte " " 		5	days " " " " 195,225,948				 81,478,584						 41.7% 11,566,841					 14.2%
Hehl	D7 60	 9 " Gametocyte " " 		7	days " " " " 751,346,454				 128,435,940				 17.1% 18,013,378					 14.0%
Oocyst	development
Oocyst	D0 61	 6 M4 Oocyst NA unsporulatedcontrol polyA+ Yes 55-150 58 22,416,214						 10,037,743						 44.8% 815,928											 8.1%
Oocyst	D4 62	 6 " " " sporulated 		4	days " " 55-150 50 20,628,790						 18,970,427						 92.0% 1,508,317								 8.0%
Oocyst	D10 63	 6 " " " " 10	days " " 55-150 50 20,243,335						 18,524,507						 91.5% 1,427,680								 7.7%
Other	samples
SR3	uninduced 64	 7 RH	cSR3 TachyzoiteHFF	cells In	vitro control polyA+ No unknown 100+100? 102,451,076				 94,223,358						 85.7% 11,359,466					 12.1%
SR3	4hr	induced 65	 7 " " " SR3-induction		4	hr " " " " 89,992,092						 82,711,487						 91.9% 9,793,519								 11.8%
SR3	8hr	induced 66	 7 " " " " 		8	hr	 " " " " 91,194,210						 83,917,767						 92.0% 10,126,194					 12.1%
SR3	24hr	induced 67	 7 " " " " 24	hr " " " " 96,979,952						 87,825,880						 90.6% 10,539,187					 12.0%
ncRNA	RH 68	 9 RH TachyzoiteHFF	cells In	vitro 33	hr ncRNA Yes 15-45 38 37,861,116						 2,061,028									 5.4% 127,575											 6.2%
ncRNA	ME49 69	 9 ME49 " " " 24	hr " " " " 34,330,519						 2,064,798									 6.0% 145,050											 7.0%
References Total	(all	samples): 5,573,795,740	 1,469,567,425	 153,771,851			
1.		Lorenzi	H	et	al.,	Nature	Communications;	2016	(ref	7) excluding	'Other': 5,120,986,775	 1,116,763,107	 111,680,860			
2.		Minot	S	et	al.,	Proc	Natl	Acad	Sci;	2012	(ref	18) Unigue	intron	junctions: 2,731,523							
3.		Reid	AJ	et	al.,	PLoS	Pathogens;	2012	(19) High	quality	strand-specific	libraries	(green): 2,354,385,967	 506,589,822				 63,627,926					
4.		This	study
5.		Pittman	KJ	et	al.,	BMC	Genomics;	2014	(20)
6.		Fritz	HM	et	al.,	PLoS1;	2012	(17) *	read	fragments	for	paired-end	libraries	(to	avoid	couble-counting);	denominator	for	FPKM	calculations		
7.		Yeoh	LM	et	al.,	Nucl	Acids	Res;	2015	(21) †	low	%	unique	mapping	reads	is	attributable	to	host	cell	RNA;	cf	ME49	time	course	in	rows	42-46)
8.		Buchholz	KR	et	al.	Eukaryot	Cell;	2011	(51) ‡	total	#	intron-spanning	reads	(ISRs);	denominator	for	ISRPM	calculations
9.		Unpublished;	available	from	ToxoDB.org  
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Table 1.  List of T. gondii RNAseq datasets used in this study (ToxoDB release 28).   
Green highlighting indicates 20 high quality samples used define the prevalence of alternative 
splicing and mechanisms of transcriptional regulation; pink highlighting indicates reasons for 
exclusion of other samples from the analyses presented in Chapter 2; see text for further 
discussion. 
 
Because strand-mapping information was not retained in the ToxoDB pipeline 
implementation of RUM, strandedness was assigned by analyzing five nucleotides up- 
and downstream of each intron to determine the most probably splice donor and 
acceptor.  Analysis of the abundance distribution of dinucleotides pairs for each intron, 
showed that (as expected) the most common splice signal (on the plus strand) was 5’-
GT/AG-3’, which is >80 times more abundant than any of the other possible 63 intron 
combinations.  5’-GC/AG-3’ and 5’-GA/AG-3’, were the next most common (enriched 1.8 
& 1.4 times, respectively).  We therefore further filtered this intron list to include only 
introns that contained the major splice signal 5’GT/AG3’.  This procedure yields a total of 
66,104 introns for examination in greater detail. 
Once strand was recovered, introns were assigned to gene structures to determine 
those fully contained within a previously-annotated gene model, those lying fully within 
intergenic regions in the draft annotation (potential extensions of existing gene models, 
or associated with previously unrecognized genes), and those overlapping draft gene 
models.  For introns associated with a specific gene, reads spanning that intron should 
be comparable to reads mapping to the mature transcript.  The abundance of intron-
spanning reads (ISRs) per million reads in the library (ISRPM) was therefore plotted as a 
function of the number of reads mapping to the assigned gene, normalized to gene size 
(FPKM = read fragments per kilobase of transcript, per million total mapped reads). 
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Preliminary analysis using all 69 RNA-seq samples in Table I revealed poor corre-
lation between intron and gene expression for a some introns, invariably attributable to 
poor quality samples in which relatively few reads could be mapped to the parasite (or 
host) genome.  These samples were therefore excluded from analysis of splice junction 
usage, as were samples for which only non-strand-specific reads are available, and 
samples involving splicing machinery mutants (pink shading in Table1).  Note, however, 
that data from all these samples remains available in ToxoDB, and were reviewed after 
the completion of our analysis of high confidence introns. 
All further analysis was conducted using a final set of 59,755 introns, from 20 sam-
ples representing all parasite life cycle stages, in multiple strains (green shading in Table 
1).  To analyze the prevalence of alternative splicing, the abundance of each intron was 
compared to its most abundant alternative(s), if any.  Data was visualized using 
DataGraph 4.1 (Visual Data Tools; Figs 2.4-2.6 & 2.12-2.13).  
Results 
Transcriptional insights from RNA-seq, applied to Toxoplasma gondii 
Prior to the development of high throughput methods for mRNA sequencing, eukar-
yotic gene finding relied upon on ab initio methods (predicting gene structure based on 
primary sequence alone), and de novo strategies informed by cDNA sequences from 
expressed sequence tags (ESTs; Burge and Karlin 1998; Salamov and Solovyev 2000; 
Wei and Brent 2006).  The much greater coverage provided by low cost RNA-seq 
methods greatly enhances gene model accuracy, however, enabling the identification of 
previously unrecognized transcripts, refinement of untranslated region (UTR) annotation, 
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definition of stage- and strain-specific transcripts, recognition of alternative splice junc-
tions, etc (Trapnell et al. 2010).  When available, additional genomic-scale datasets 
(chromatin marks, transcription factor binding sites, protein expression data, etc) can 
also be exploited further improve the accuracy of gene model prediction (Lamesch et al. 
2012).  
TgHXGPRT was the first alternatively-spliced gene identified in the protozoan para-
site Toxoplasma gondii (Donald et al. 1996), based on the presence or absence of an 
'exon skip' polymorphism encoding a 49 amino acid insertion including an acylation motif 
responsible for protein association with parasite membranes (Chaudhary et al. 2005).  
The reference model in the official GenBank annotation (and ToxoDB) includes this 
exon-skip polymorphism as exon III (Fig 2.1 track 1; blue indicates transcription from left-
to-right, i.e. on the forward, or top strand).  Numerous ESTs map to TgHXGPRT (track 
2), confirming both splice variants: exon III is missing from eleven ESTs (HXGPRT-I), 
but included in six (HXGPRT-II).  Western blotting indicates similar relative abundance of 
HXGPRT-I vs HXGPRT-II at the protein level (Chaudhary et al. 2005).  This well-valid-
ated example of an alternatively-spliced gene was used as a positive control to define 
and assess parameters for alternative transcript identification genome-wide. 
RNA-seq data provide vastly greater experimental support: average depth for the 
experiment presented in Fig 2.1 is >700 reads (track 3; ~29.5 on the log scale plot shown 
in track 5). The most common apparent transcript initiation site (in this steady-state 
analysis) occurs at ~6,795,950 (heavy magenta arrow), ~100 nt downstream of the 
annotated 5’ end.  In keeping with common conventions from the pre-RNA-seq era, this 
gene was originally annotated based on the longest, rather than the most abundant 
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cDNA clone.  Log-scale representation reveals the range of 5’ ends identified by RNA-
seq, although we cannot exclude the possibility of 5’ exonuclease activity or premature 
termination during reverse transcription.  Most transcripts appear to terminate close to 
the annotated 3’ end (filled magenta circle), although alternative low abundance termina-
tion sites are also evident, most prominently ~500 nt downstream (open magenta circle). 
						TgME49_chrVIII	
1	
2	
3	
4	
5	
Annotated	Genes	(UTRs	in	gray)	
EST	Alignments	
mRNAseq	Coverage	–	TgCZ-H3	Tachyzoites	(Hehl)	(linear	plot)	
Splice	Site	JuncMons	(union	of	all	experiments)	
mRNAseq	Coverage	–	TgCZ-H3	Tachyzoites	(Hehl)	(log	plot)	
I												II												III													IV						V	
 
Figure 2.1.  Reading RNA-seq data.   
The annotated T. gondii HXGPRT gene (TgME49_200320), aligned to EST sequences and RNA-
seq data (both linear & log coverage plots), including intron-spanning reads (brackets).  Note the 
presence of multiple 5’ ends (at steady-state), likely corresponding to multiple promoters 
(magenta arrows), of which only the longest and most prominent would permit excision of intron I 
(which lies within the 5’UTR).  EST coverage in intron I was previously misinterpreted as intron 
read-through variants (Donald et al. 1996).  Magenta brackets highlight the well-validated exon 
skip variant (star) responsible for membrane association of HXGPRT isoform II (Donald et al. 
1996; Chaudhary et al. 2005).  Multiple (low abundance) 3’ ends are also observed (circles). 
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Six well-defined exons are clearly identifiable in the RNA-seq coverage plots, cor-
responding precisely to the annotatation TgHXGPRT-II.  Exon III (magenta star) is less 
abundant than the other five, however (seen most clearly in the linear representation; 
track 3), providing evidence of alternative splicing, consistent with ESTs, Northern blot-
ting, protein immunoprecipitation, proteomics and protein structure data (ToxoDB.org 
and (Chaudhary et al. 2005)). RNA-seq reads that map across intron junctions (intron-
spanning reads; ISRs) are indicated by horizontal brackets in track 4 (pooled information 
from numerous experiments). Magenta brackets highlight introns corresponding to the 
known HXGPRT exon-skip polymorphism: for the experiment shown (TgCZ-H3 tachy-
zoites), 149 reads could be unequivocally mapped to intron II, 187 reads span intron III, 
and 180 reads span introns II+III (excising exon III), defining the HXGPRT-I transcript. 
Pooling all available experimental data (from multiple samples) provides overwhelming 
support for this exon-skip polymorphism (8573, 11475, and 12785 reads, respectively; 
ToxoDB release 28). 
Intron-spanning reads (ISRs) also identify numerous unannotated introns, but these 
are significantly less abundant.  For example, while intron I is supported by 391 reads in 
the experiment shown (27K in all studies), an alternative splice donor 112 nt upstream is 
supported by 7 ISRs and 227 ISRs respectively, and this alternative intron is also 
supported by EST data; two ISRs (61) support yet another alternative donor 8 nt further 
upstream.  Note that none of these alternatives affects the predicted protein sequence, 
however, as intron I lies within the 5’ untranslated region (UTR).  Alternative ISRs map-
ping to the HXGPRT coding sequence also seem unlikely to be biologically meaningful, 
as the most common (87 reads in all studies, but none in the experiment shown) extends 
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intron IV by 17 nt, which would introduce a translational frame shift and premature ter-
mination eliminating most of the phosphoribosyl transferase domain (Pfam00156). 
In addition to defining the exon skip polymorphism distinguishing HXGPRT-I & II, 
the original cDNA clones were interpreted to suggest retention of intron I in some trans-
cripts (Chaudhary et al. 2005).  Read coverage within intron I is significantly higher than 
other introns (~10% exon depth vs <5% for other introns), but careful examination of the 
RNA-seq data reveals that coverage is non-uniform, displaying gradually increasing 
depth in the direction of transcription, suggesting alternative promoters (lighter magenta 
arrows). This interpretation is consistent with both EST evidence and review of the 
original cDNA clones.  Transcript initiation within intron I would of course preclude intron 
excision. 
In sum, using the highly-curated TgHXGPRT gene as a positive control for reanal-
ysis based on RNA-seq data improves the definition of UTRs, confirms exon boundary 
annotation and a known exon-skip variant, permits identification of additional rare (and 
probably biologically meaningless) splice variants, and reveals that the previously-
described intron retention is more likely attributable to alternative transcript initiation 
within intron I.  Applying such analyses genome-wide offers the prospect of significantly 
improved gene model definition.  For example, as shown in Fig 2.2, previous annotation 
(ToxoDB release 7.3, produced without the benefit of RNA-seq data) failed to define 5’ 
UTRs for 5777 of the 8323 protein-coding genes in the reference T. gondii annotation, 
and 3’ UTRs for 4859 (gray bars).  Incorporating RNA-seq information now identifies 
7219 5’ UTRs and 7296 3’ UTRs, with a modal 5’ UTR length of ~750 nt, and 3’ UTR 
length of ~500, similar to HXGPRT, above (blue in Fig 2.2). 
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Fig 2.3 presents an expanded genomic region, extending upstream of HXGPRT 
(the right-most gene in this panel), including RNA-seq evidence from both tachyzoite and 
gametocyte (enteroepithelial) stage parasites (Hehl et al. 2015), along with additional 
genomic-scale data from chromatin immunoprecipitation studies (Gissot et al. 2007). 
These experiments support the reference annotation of TgME49_200310 (immediately 
to the left of HXGPRT), which is heavily transcribed in tachyzoites (tracks 5,6,8), gamet-
ocytes (track 10), and other life cycle stages (not shown).  Low abundance unannotated 
ISRs never exceed 2% of annotated intron abundance for this gene.  Chromatin activa-
tion marks (H3K4me3 & H3K9ac; track 1) are consistent with a 242 nt region mediating 
divergent transcription of TgME49_200310 & 200320 (HXGPRT). 
 
Figure 2.2.  Length distribu-
tion of annotated UTRs.   
Lengths of UTRs before 
(gray) and after (blue) incor-
porating RNA-seq data into 
gene finding algorithms. 
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Figure 2.3.  Strand-specific mRNA-seq reveals a multitude of alternative splice variants 
and antisense RNAs, including long non-coding RNAs.   
Genome browser view of a 22kb region (TgME49_chrVIII: 6778-6800kb) displaying publicly 
available chromatin marks (H3K4me3 & H3K9ac, track 1), annotated gene models (including 
HXGPRT, at right, track 3), non strand-specific mRNA-seq data (tracks 5,6), and selected strand-
specific mRNA-seq data from this study (tracks 7-10).  Color intensity in track 4 indicates 10-fold 
differences in the abundance of junctional reads (dark brown > light brown > orange). Arrows and 
circles (tracks 8,10) indicate likely 5’ and 3’ termini, respectively; green shadowed transcript (track 
10) proposes a corrected gene model; the green box highlights a likely long noncoding RNA 
(lncRNA).  See text for further discussion. 
 
In contrast, RNA-seq data argues for revised annotation of the adjacent region 
(ChrVIII: 6.778-6.792 Mb).  Ab initio gene-finding methods previously suggested a 
seven-exon transcript (TgME49_000300; track 2), while more recent annotation taking 
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(limited, non-strand-specific) tachyzoite-stage RNA-seq data into account were used to 
define two transcripts: TgME49_200300 & 200295 (track 3).  Strand-specific sequencing 
of multiple life cycle stages helps to reconcile these discordant views.  In tachyzoite 
stage parasites (track 8), steady-state RNA levels indicate two 5’ ends, consistent with 
the above gene models (light green arrows), but provide no support for either exon I or 
intron I from the first draft annotation (TgME49_000300).  In gametocyte stages, how-
ever (track 10), transcription initiates far upstream (heavy green arrow), at a position 
consistent with chromatin modification data (track 1), and similar to the original ab initio 
predictions.  The resulting 17-exon gene model (green shading) encompasses all exons 
previously suggested by any annotation, along with additional exons revealed by high-
depth sequencing (mostly within the 3’UTR).  As noted for the HXGPRT gene, while 
CDS intron excision is generally efficient, relatively high transcript abundance is some-
times observed within UTR introns, due to a combination of alternative transcript initia-
tion, termination, splicing, and/or inefficient intron excision. 
Interestingly, while the first exon of this gene (from ~6.790-6.792 Mb) is only 
observed in gametocyte stage parasites (track 10), this region is heavily transcribed on 
the opposite (forward, blue) strand in tachyzoites (track 7).  The lack of an open reading 
frame on this strand, and lack of chromatin marks typically associated with active Pol II-
mediated mRNA transcription (track 1) suggests that it is a long non-coding RNA 
(lncRNA).  This interpretation is consistent with the low prevalence of introns mapping to 
this transcript:  
Just 39 reads were observed spanning the most abundant intron seen in this experi-
ment (97 in all experiments), at least 4-fold fewer than expected based on transcript 
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abundance (compare with read coverage troughs corresponding to introns for the 
HXGPRT gene, for example).  This lncRNA is missing in gametocytes, i.e. it’s presence 
is inversely correlated with transcription on the reverse (red) strand. 
Genome-wide analysis of putative introns, and alternatively splicing 
In order to exploit the utility of RNA-seq data for improving genome annotation, 
including the identification of stage-specificity, UTRs, alternative splicing, etc, we gener-
ated several strand-specific libraries from various parasite strains, at different times after 
infection of human host cells in vitro (see Methods), and considered the resulting RNA-
seq data in parallel with all other T. gondii RNA-seq datasets available in the ToxoDB 
database (release 28).  The 69 samples summarized in Table 1 (above) derive from nine 
studies involving various parasite strains, mutants, life cycle stages and host species. 
A total of 1.1 x 109 mRNA-seq reads from wild-type parasites map uniquely to the T. 
gondii (not host) genome, and define ~2.7M splice junctions.  The vast majority of these 
correspond to the U2 (GT/GC-AG) or U12 (GA-AG) splice consensus, suggesting genu-
ine spliceosomal origin, but >90% were observed at very low abundance (<6 total reads, 
or <3 in the most abundant sample), and were not analyzed further.  Introns whose 
strand could not be unambiguously determined were also excluded from this study.  
Further restricting analysis to strand-specific libraries with >106 parasite-specific reads 
leaves a total of 20 samples – 11 of which were generated specifically for this study, 
(and 16 of which are presented here for the first time).  These samples provide support 
for >97% of the ~40K introns annotated in the current reference genome, in addition to 
~20K unannotated introns that might reasonably be considered for inclusion in the 
reference annotation.  Adding back ~1K annotated introns unsupported by RNA-seq 
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evidence yields a total of 59,755 candidate introns for further analysis (see Supple-
mental File 1). 
Assuming uniform read coverage across all full-length transcripts, unambiguous 
mapping, and efficient splicing … and ignoring alternative splicing for the moment, one 
would expect a linear relationship between the abundance of intron-spanning reads 
(ISRs) and all reads that map to a transcript, normalized for transcript length (Venables 
et al. 2008; Katz et al. 2010).  All introns were mapped to individual genes or intergenic 
regions, and intron abundance was plotted as a function of transcript abundance, as 
shown in Figure 2.4.  Intron abundance (ISRPM) is defined for each junction as the 
number of ISRs spanning that junction, normalized to the total number of ISRs mapped 
in that experiment (in millions).  Transcript abundance (FPKM) is defined for each gene 
as the number of reads (or read pairs) mapping to that gene, normalized to gene length 
(in kilobases) and the total number of read (pairs) mapped in that experiment (in 
millions). 
The data in Fig 2.4 are derived from a single experiment on the acutely lytic (tachy-
zoite) stage of T. gondii strain CZ-H3 (Basso et al. 2013; Juránková et al. 2013).  Anno-
tated introns are shown in black, while unannotated introns are shown in gray; unanno-
tated intergenic introns are not displayed, as their FPKM values are not readily defined.  
Two populations of introns are immediately evident: low abundance introns mapping to 
genes at various expression levels (shaded area in Fig 2.4), and introns that appear to 
be efficiently excised (i.e. ISRPM proportional to FPKM, regardless of expression level; 
diagonal in Fig 2.4).  It is clear that the latter are predominantly annotated (black), while 
the former are predominantly unannotated (gray).  
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Figure 2.4.  The abundance of annotated introns is overwhelmingly correlated with total 
transcript abundance. 
Intron-spanning read abundance (ISRPM) as a function of transcript coverage (FPKM), for 
annotated introns (black) and novel (unannotated) introns (gray), in T. gondii tachyzoites.  Just 
31K introns are reproducibly observed and map to annotated genes at the expected abundance 
levels.  Most of the introns observed at levels comparable to transcript abundance are annotated, 
i.e. black dots lie along the diagonal.  Magenta dots highlight HXGPRT introns (see Fig 2.1), 
including (from top to bottom) the invariably-spliced introns IV & V and the slightly less-efficiently 
excised 5’UTR intron I; alternatively-spliced introns II, III and the intron II-III exon skip isoform; 
and several low abundance unannotated introns (mostly off-scale). 
 
Assuming the reference annotation provides some approximation of the truth (even 
if it cannot be considered a gold standard), and that systematic errors in gene model 
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prediction are not overwhelming, the current annotation can be used to define para-
meters for intron abundance and splicing efficiency that minimize false discovery (Sup-
plementary Fig S1).  As quantified in Table 2A, the majority of introns that are efficiently 
excised in tachyzoite-stage parasites (ISRPM/FPKM ≥0.2) are annotated (98%), and the 
majority of annotated introns (81%) are efficiently excised.  Conversely, the majority of 
low abundance introns (ISRPM <1, regardless of FPKM) are not included in the refer-
ence annotation (57%), and the majority of unannotated introns are low abundance 
(88%), even after exclusion of >2.5M very low abundance or poor quality unannotated 
introns (see above). 
Table	2B.		Alternative	splicing
Reference	Intron Alternative	Intron	(ISRPM	≥1	only)
Intron Abundance Excision	eff'y Tachyzoites Gametocytes Max	from Abundance Excision	eff'y Unannotated High	Eff'y	(ISRPM/FPKM	≥	0.2) Annotated High	Eff'y	(ISRPM/FPKM ≥ 0.2)
Annotation (ISRPM) (ISRPM/FPKM) (strain	CZ-H3) (CZ-H3,	d7) ANY	sample (ISRPM) (ISRPM/FPKM) Low	Eff'y	(<0.2) Ref	>	Alt Alt	>	Ref Low	Eff'y	(<0.2) Ref	>	Alt Alt	>	Ref
Annotated High	(≥10) OK	(≥0.2) 18,715 15,592 29,584 Annotated High	(≥10) OK	(≥0.2) 23,983 4,569 838 194
39,653 Med	(1-10) " 12,805 18,259 7,325 39,653 Med	(1-10) " 6,957 72 164 132
Low	(0.1-1) " 627 1,010 51 Low	(0.1-1) " 47 2 0 2
High	(≥10) Low	(<0.2) 51 37 654 High	(≥10) Low	(<0.2) 471 123 60
Med	(1-10) " 370 245 413 Med	(1-10) " 271 37 105
Low	(0.1-1) " 197 339 141 Low	(0.1-1) " 69 13 59
Very	Low	(<0.1) NA 6,888 4,171 1,485 Very	Low	(<0.1) NA 1,079 56 350
Unannotated High	(≥10) OK	(≥0.2) 154 112 1,108 Unannotated High	(≥10) OK	(≥0.2) 387 67 56 48 114 151 285
11,834 Med	(1-10) " 306 706 1,739 11,834 Med	(1-10) " 754 31 35 65 50 123 681
Low	(0.1-1) " 44 163 53 Low	(0.1-1) " 28 0 1 4 3 1 16
High	(≥10) Low	(<0.2) 72 102 537 High	(≥10) Low	(<0.2) 95 67 41 38 296
Med	(1-10) " 900 441 3,538 Med	(1-10) " 2,829 313 190 84 122
Low	(0.1-1) " 881 1,295 1,301 Low	(0.1-1) " 946 59 96 39 161
Very	Low	(<0.1) NA 9,477 9,015 3,558 Very	Low	(<0.1) NA 634 123 185 68 2,548
Intergenic	or High	(≥10) 75 210 1,230 Intergenic	or High	(≥10) 1,220 5 5
ambiguous Med	(1-10) 526 1,442 3,809 ambiguous Med	(1-10) 3,771 6 32
8,268 Low	(0.1-1) 392 1,193 1,005 8,268 Low	(0.1-1) 989 0 16
Very	Low	(<0.1) 7,275 5,423 2,224 Very	Low	(<0.1) 2,209 0 15
Total: 59,755 59,755 59,755 Total: 59,755
Extremely	Low	(<<0.1) Previously	excluded	(unannotated): 2,535,138 Extremely	Low	(<<0.1) 2,535,138 Previously	excluded	(unannotated)
Table	2A.		Intron	abundance	&	annotation	in	various	samples
None
 
Table 2.  Intron abundance and alternative splicing in T. gondii.  
Red and orange lettering indicates likely false-positives, i.e. annotated introns never observed 
and/or excised in any sample in this study; green lettering indicates false negatives, i.e. unanno-
tated introns observed at levels consistent with transcript abundance. A, Intron abundance in 
tachyzoites, gametocytes, or any sample, stratified by splicing efficiency and annotation status.  
Green, red and blue shading reflects the relative abundance of annotated, unannotated, and non-
genic introns in each sample.  B, Stratification of all introns (from right-most column in panel A) 
based on the abundance, splicing efficiency and annotation status of alternative (overlapping) 
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introns.  Orange shading reflects unannotated introns that should probably be considered 
alternative splice junctions; green, currently unannotated introns that should replace the existing 
annotation; red, annotated introns that should be removed from the current annotation; blue, 
annotated introns that should be downgraded due to more abundant unannotated alternatives. 
 
All of the HXGPRT introns discussed above (cf. Fig 2A) are appropriately repre-
sented in Fig 2.4 (magenta circles; filled = annotated; open = unannotated).  The three 
introns that are always excised (I, IV & V) lie close to the ISRPM = FPKM diagonal, while 
introns II & III, which define the exon cassette responsible for HXGPRT isoform II, are 
less abundant (ISRPM/FPKM ~0.3), as is intron II-III, representing the alternative exon-
skip variant responsible for HXGPRT isoform I (open circle).  All three of these alterna-
tively-spliced introns still lie within the true-positive sector (ISRPM >1 and >20% FPKM), 
but less plausible HXGPRT introns do not (including several that are off-scale on this 
plot).  While most annotated introns lie within the true-positive sector in this CZ-H3 
tachyzoite sample, 8133 appear as possible false positives in Fig 2.4, i.e. ISRPM <1 
and/or ISRPM/FPKM <0.2.  Considering other samples, however, reveals that the 
majority of these introns are expressed in other life cycle stages, as discussed below. 
For example, while a similar distribution of annotated and unannotated introns is 
observed in gametocyte stage parasites (Fig 2.5A, Table 2A), most of the apparent 
tachyzoite stage false-positives are abundantly expressed and efficiently excised in 
gametocytes (orange datapoints in Fig 2.5).  ~79% of all annotated introns are support-
ed in tachyzoites, and 85% in gametocytes, but only 73% were observed in both life 
cycle stages, while 6-12% were stage-specific (Table 2A).  Combining all 20 of the high 
quality datasets used in this study (green shading in Table 1) and plotting the maximum 
evidence for each intron (in any experiment) against transcript abundance in that experi-
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ment (Fig 2.5B), provides strong support for 93% of all annotated introns at ISRPM ≥1 
and ISRPM/FPKM ≥0.2, and 75% at ISRPM ≥10 (Table 2A), i.e. there are relatively few 
false positives in the current T. gondii reference annotation.  It is likely that more exten-
sive sequencing, including additional strains, life cycle stages, conditions and treatments 
would reduce this number still further. 
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Figure 2.5.  Genome-wide identification of implausible annotated introns (FP). 
Intron-spanning read abundance (ISRPM) as a function of transcript coverage (FPKM) for anno-
tated introns (black) and novel (unannotated) introns (gray).  A, T. gondii gametocytes display a 
similar pattern with most introns observed at levels comparable to transcript abundance being 
annotated, i.e. black dots lie along the diagonal, but many introns not expressed in tachyzoites 
(black dots at bottom or below the diagonal in Fig 2.4) are expressed in gametocytes (orange), 
often at transcriptionally-appropriate levels.  B, ISRPM vs FPKM values for all putative introns, in 
whichever sample that intron is maximally evident; note that this provides further separation of 
black and gray dots, leaving few false positives. 
 
Potential false negatives, i.e. unannotated introns that map to genes with a maxi-
mum abundance consistent with mRNA levels (~7% of plausible intron candidates), are 
represented by gray datapoints overlapping the dominant black cloud in Fig 2.5B.  It is 
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interesting that most of these candidate splice junctions display somewhat lower abund-
ance and/or inefficient excision relative to expectations based on FPKM values, i.e. they 
are slightly offset towards lower edge of the black diagonal cloud representing annotated 
introns (true positives).  This observation suggests that they may represent subdominant 
splice variants rather than fully false negatives, as is the case for introns attributable to 
HXGPRT exon-skip variants.  (Note that HXGPRT is very highly expressed in gameto-
cytes, at levels ~20-fold greater than in tachyzoites; compare pink dots in Fig 2.5 & 2.4.) 
To directly assess the relationship between possible false negatives and existing 
intron annotation, we compared the maximal excision efficiency (ISRPM/FPKM) for each 
intron (vertical axis in Fig 2.6) with the excision efficiency of the maximum alternative 
overlapping intron (horizontal axis).  The four quadrants of this figure, defined by exci-
sion efficiencies of greater or less than 20% in the reference vs overlapping alternative 
introns represent: 
• Top Left:  Introns expressed and excised at comparable levels (ISRPM/FPKM ≈ 1) 
and overlapping alternative introns that are ~5-5000-fold less efficiently spliced.  
This quadrant is dominated by annotated introns (black), including the efficiently-
spliced HXGPRT introns I, IV & V.  Many additional annotated introns lack any 
plausible overlapping alternative (off-scale to the left). 
• Bottom Right:  Introns that are inefficiently spliced but overlap alternatives excised 
at expected levels, i.e. the reciprocal of the above.  This quadrant is dominated by 
unannotated introns (blue), including implausible alternatives to HXGPRT introns I, 
IV & V (cf. Figs 1A&C), and many more off-scale low. 
• Bottom Left (gray shading):  Low abundance and/or inefficiently spliced introns that 
overlap alternatives that are also low abundance and/or inefficiently spliced (gray). 
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• Top Right (yellow shading):  Introns that are abundant and efficiently spliced, and 
overlap alternatives that are also abundant and efficiently spliced, such as those for 
HXGPRT introns II & III (solid magenta dots) and the exon-skip variant represented 
by HXGPRT intron II-III (open magenta circle).  (Note that stage-specific alternative 
exons would be expected to be even more efficiently excised.) 
efficiently-spliced
introns (I,IV,V)
exon-skip
variants
introns
(II,III vs II-III)
(appropriately)
unannotated
introns
alternative
Annotated intron with Unannotated alternative
Unannotated intron with Annotated alternative 
Unannotated introns, Unannotated alternative
   HXGPRT introns (unannotated) 	
 
Figure 2.6.  Genome-wide identification of likely unannotated introns (FN), including alter-
natively-spliced isoforms.   
Plotting splicing efficiency (ISRPM/FPKM) from Fig 2.5B against splicing efficiency for the most 
prevalent overlapping alternative (Additional File 1) identifies unannotated introns that should be 
considered for inclusion in the reference annotation (~7.2% of annotated introns), including likely 
splice variants (~3.6% of annotated introns; yellow quadrant); Black dots indicate annotated 
introns overlapping unannotated alternatives; blue dots indicate unannotated introns overlapping 
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annotated alternatives, and gray dots denote unannotated introns overlapping unannotated 
alternatives.  See text for further discussion. 
 
Summary statistics for overlapping introns are provided in Table 2B.  Considering Tables 
2A & 2B in aggregate, and comparing with Fig 2.6, permits an objective analysis of 
current annotation status, using metrics that should also be applicable to other systems: 
• True Positives:  93% of T. gondii introns annotated in ToxoDB release 28 are 
abundantly or moderately expressed and efficiently excised in at least one 
experimental sample (black datapoints in the upper half of Fig 2.6): 29,584 display 
maximal abundance ≥10 ISRPM and splicing efficiency (ISRPM/FPKM) ≥20%; 7325 
display maximal ISRPM from 1-10 (and ISRPM/FPKM ≥20%).  84% of these 
(23,983 + 6957) show no overlap with any plausible alternative intron (off-scale left 
in Fig 2.6).  5969 overlap plausible alternatives, but 78% of those alternatives (4569 
+ 72) are only weakly expressed and/or inefficiently excised (horizontal black cloud 
in Fig 2.6).  Just 1328 plausibly-expressed and efficiently-spliced annotated introns 
were found to overlap plausible unannotated alternatives (black dots within the 
yellow shaded region).  Among these, the annotated intron was most prominent 
75% of the time (838 + 164; orange shading in Table 2B; above the diagonal in Fig 
2.6).  Only 326 (194 + 132) overlap unannotated introns that are more prominent 
than well-supported annotated introns (green shading in Table 2B; black dots below 
the diagonal in the yellow-shaded region of Fig 2.6). 
• False Positives:  2744 annotated introns (red & orange lettering in Table 2A) were 
identified as likely false positives due to low evidence (1677) and/or inefficient exci-
sion (1208), and are represented by black dots in the lower half of Fig 2.6.  576 
overlap plausible unannotated introns that could be considered as replacement 
annotation (red/orange letting and green shading in Table 2B; black dots in the 
lower right-hand quadrant of Fig 2.6).  Many of these share either a donor or 
acceptor splice site with the unsupported annotation (see below). 
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• False Negatives:  6922 unannotated introns map to genes in the current reference 
annotation and are abundantly expressed in at least one sample, but only 41% of 
these (1108 + 1739) are also efficiently excised.  Most (1444; 51%) overlap plaus-
ible alternative introns (gray & blue dots in the upper half of Fig 2.6), which are 
usually more probable annotated introns (681 + 285 = 966; blue dots below the 
diagonal in the yellow shaded region of Fig 2.6).  A few (151 + 123 = 274) represent 
introns that are more probable alternatives to the existing annotation (blue dots 
above the diagonal in the yellow shaded region in Fig 2.6; blue shading in Table 
2B), and fewer still should probably supplant the existing annotation (just 114 + 50 = 
164; blue dots in the upper-left quadrant, the reciprocal of black dots in the lower 
right-hand quadrant, described above; red shading in Table 2B).  In addition, 302 
plausible unannotated introns overlap unannotated alternatives (gray dots in the 
upper half of Fig 2.6), and 1141 high confidence unannotated introns do not overlap 
other plausible introns (Table 2B; off-scale left in Fig 2.6). 
• True Negatives:  Even excluding the millions of very low abundance junctions pre-
viously discarded, most unannotated introns are not significantly expressed and/or 
processed, in any sample (black numbers in the right-hand column of Table 2A). 
• Intergenic Introns:  Introns observed in RNA-seq experiments that fail to map to 
annotated genes are relatively rare, but 1230 + 3809 = 5039 display plausible 
abundance (Table 2B), suggesting extended gene models or previously unanno-
tated genes.  Many of these are most evident in non-tachyzoite stage parasites, 
suggesting stage-specific expression, and reflecting the dominance of data from the 
acutely-lytic in vitro tachyzoites in generating the current reference annotation. 
Implications for T. gondii annotation 
Exploiting the parameters defined above, various transformations and filtering of 
data in Additional File 1 were used to identify potential cases of erroneous annotation in 
the reference T. gondii genome, including alternative splice variants and novel gene 
models.  Representative examples are provided in Figs 2.7-11 (and highlighted in Figs 
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2.12 & 13).  These results are currently being incorporated into the reference genome 
database. 
TgME49_234450 (Fig 2.7) is annotated as ribosomal small subunit protein Rps15A, 
based on highly conserved protein sequence motifs across all species.  The current 
structural annotation describes two introns, but overlapping alternatives (defined based 
on the analysis presented in Fig 2.6) reveal a skipped exon within the first intron 
(magenta star) in ~30% of tachyzoite transcripts.  This organization (and abundance) is 
similar to the HXGPRT cassette exon (Fig 2.1), except that the reference annotation for 
HXGPRT includes the cassette exon, whereas the annotated RPS15A transcript does 
not.  In contrast to the 147 nt HXGPRT cassette, which encodes 49 amino acids, the 69 
nt RPS15 cassette exon is predicted to result in premature protein translation, due to an 
internal stop codon (Supplementary Fig S2).  Close inspection of the genome sequence 
and multiple sequence alignments reveals that the annotated translation initiation site is 
likely incorrect.  An alternative ATG immediately downstream of the cassette exon offers 
better sequence context for translation and protein stability (Matrajt et al. 2004), and 
yields a product that aligns with RPS15A proteins from other species across its entire 
130 amino acid length (Fig 2.7, bottom). 
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		TgME49_chrX:4,396,501..4,399,500 	TgME49_234450	(Rps15a)	
 
 
Figure 2.7.  Genome browser view & multiple sequence alignment of TgRps15a. 
Top, Genome annotation and selected RNA-seq tracks from tachyzoites, bradyzoites, and/or 
gametocytes (as labeled).  Note that solid blue tracks are scaled logarithmically while tracks 
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shown in semi-transparent overlay are linear (also note different scales, selected to highlight 
alternative splicing).  As in Fig 2.1, arrows and circles indicate transcript termini, stars indicate 
variants discussed in the text.  In contrast to Fig 2.1, two tracks display candidate introns (brack-
ets): the ‘filtered’ track is restricted to display only those introns that pass the abundance and 
efficiency criteria described in this dissertation.  Bottom, Multiple sequence alignment of 
TgRPS15a with various other species.  Current annotation includes a 101 amino acid N-terminal 
exon (yellow) upstream of the most plausible initiation codon (green); inclusion of the alterna-
tively-spliced cassette exon noted above would introduce 10 amino acids ending in a premature 
termination codon (turquoise). 
 
Moreover, while proteomics evidence provides ample support for the body of the 
protein (Wastling et al. 2009; and other data in ToxoDB.org), there is no evidence for 
translation of the 101 amino acid N-terminal extension predicted by the current annota-
tion.  In sum, there is strong support for an exon-skip variant at this locus, and inclusion 
of the cassette may be stage-specific (more common in bradyzoites, less common in 
gametocytes), but these alternative splice products likely affect the 5’UTR only.  As 
indicated by the RNA-seq data, and supported by the presence of chromatin activation 
marks (Gissot et al. 2007; ToxoDB.org) the annotated transcription start site corres-
ponds to the longest potential transcript, but not the most abundant.  The annotated UTR 
represents <0.1% of transcripts; most transcription initiates >500 nt downstream, just 
upstream of intron I. 
The availability of RNA-seq data dramatically improves T. gondii UTR annotation 
(cf. Fig 2.2), but in general, the algorithms employed (Bernal, Crammer, and Pereira 
2012; Bernal and Pereira 2012) appear to be too greedy, annotating the longest, rather 
than the most abundant UTRs.  Transcript initiation sites, including the use of stage-
specific promoters, can dramatically impact gene models, as it is of course impossible to 
excise sequences that are not transcribed.  Transforming the reference data (Additional 
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File 1) to examine stage-specific intron usage (see below, Fig 2.13) highlights Isocitrate 
Dehydrogenase (TgME49_266760), among many other genes.  As shown in Fig 2.8, this 
gene appears to be transcribed from two promoters: a low-level constitutive promoter, 
and a 20-fold more potent gametocyte-specific promoter ~800 nt downstream, within 
intron I. 
		TgME49_chrIX:975,001..979,500 	TgME49_266760	(Isocitrate	DH)	
 
Figure 2.8.  Genome browser view of alternatively-spliced Isocitrate DH. 
Genome annotation and selected RNA-seq tracks from tachyzoites and gametocytes.  Note that 
red tracks are scaled logarithmically,	while tracks shown in semi-transparent overlay are linear 
(also note different scales, selected to highlight alternative splicing).  Arrows and circles indicate 
transcript termini, stars indicate variants discussed in the text.  Two tracks display candidate 
introns (brackets): the ‘filtered’ track is restricted to display only those introns that pass the 
abundance and efficiency criteria described in this dissertation. 
 
As a result, tachyzoite transcripts match the annotated gene model, but gametocyte 
transcripts lack exon I, initiating within the intron and therefore containing a longer 
“second” exon.  As observed for RPS15A (Fig 2.7), multiple sequence alignment (Sup-
plementary Fig S3) and analysis of available proteomics (Xia et al. 2008) data suggests 
that the annotated translation initiation codon for TgME49_266760 is incorrect, and 
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translation begins within the second exon, downstream of intron I, yielding the same 
mature protein product in both tachyzoite and gametocyte-stage parasites. 
Although relatively infrequent, alternative splicing that affects the protein coding 
sequence is occasionally observed, as in TgME49_278830, which encodes glucose-6-
phosphate dihydrogenase (Fig 2.9A, displaying just the first 4 exons of this 21 exon 
transcript).  Multiple promoters yield a diversity of 5’ ends, affecting the selection of 
splice donors for intron I (which lies entirely within the UTR).  Two alternatives were also 
observed for Intron II, which lies within the protein coding sequence: the annotated intron 
predominates, but a splice acceptor variant is also observed, resulting in 60 nt of 
additional coding sequence adding 20 amino acids to the mature protein (magenta star) 
(Supplementary Fig S4).  In contrast to the examples cited above, the annotated 
translation start displays plausible sequence context (although an in-frame ATG 48 nt 
downstream within the same exon is even better), and no alternative initiation codon is 
present upstream of highly conserved protein sequences.  Experimental proteomics 
evidence also confirms supports usage of the second ATG (Xia et al. 2008). 
As indicated in Fig 2.9B, the alternative (longer) G6PDH transcript was observed in 
tachyzoites from multiple parasite strains, but not in mature bradyzoites, gametocytes, or 
unsporulated or sporulated oocysts (also seen in bradyzoite samples generated in vitro, 
which contain numerous tachyzoites; Dzierszinski et al. 2004; Soete, Camus, and 
Dubremetz 1993).  Interestingly, in two separate time courses examining transcription at 
various times post-infection, utilization of the alternative splice acceptor was most 
common early during intracellular replication (see Supplementary Fig S5 data for all 
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RNA-seq data on this differentially-spliced intron, including multiple strains with lower 
coverage data). 
A		TgME49_chrXII:5,832,501..5,837,500 	TgME49_278830	(G6PDH)	 TgME49_278830	(G6PDH)	intron	2Samples # Annotated Alternative Ratio51 All	Tachyzoites 51 1062 646 0.61
9 RH/GT1 9 150 80 0.53
9 ME49/CZH3 9 290 294 1.01
10 VEG 10 425 213 0.50
2 hr	2 2 15 32 2.13
2 hr	4 2 15 25 1.67
2 hr	8 2 4 8 2.00
2 hr	16 2 12 12 1.00
2 hr	36 2 160 92 0.58
2 hr	44 2 123 87 0.71
3 All	Bradyzoites 3 175 63 0.36
1 In	vitro	 Bz 1 79 58 0.73
2 In	vivo	Bz 2 96 5 0.05
3 All	Gametocytes 3 548 4 0.01
1 d3 1 21 1 0.05
1 d5 1 217 2 0.01
1 d7 1 310 1 0.00
3 All	Oocysts 3 900 13 0.01
1 d0 1 11 0 0.00
1 d4 1 362 1 0.00
1 d10 1 527 12 0.02
B	
 
Figure 2.9.  Genome browser view of alternatively-spliced G6PDH and Intron II abundance.   
A, Genome annotation and selected RNA-seq tracks from tachyzoites and gametocytes.  Note 
that blue tracks are scaled logarithmically,	while tracks shown in semi-transparent overlay are 
linear (note different scales, selected to highlight alternative splicing).  Arrows and circles indicate 
transcript termini, stars indicate variants discussed in the text.  Two tracks display candidate 
introns (brackets): the ‘filtered’ track is restricted to display only those introns passing the abun-
dance and efficiency criteria described in this thesis.  B, G6PDH Intron II abundance.  Intron 
excision frequency for G6PDH splice acceptor variants for all RNA-seq samples (Table 1), strati-
fied by parasite strain, time post-infection (for tachyzoites), and life cycle stage. 
 
As noted in Table 2, several thousand introns map to the T. gondii genome outside 
of annotated genes, and display abundance consistent with splice sites for known 
genes.  In order to estimate the number of unannotated protein-coding genes in the 
parasite genome, we examined a randomly selected subset of all intergenic introns, and 
also a subset of those with ISRPM >35.  In addition, we manually curated all intergenic 
regions within a 1 Mb chromosomal span.  All of these analyses suggest that the current 
reference genome annotation is lacking ~300 protein-coding genes (including single 
exon genes), most of which are specifically expressed in non-tachyzoite stages, for 
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which data has only recently become available (from this study and others).  These 
unannotated genes account for ~1/3 of all plausible intergenic introns.  For example, Fig 
2.10 shows a 5-exon gene on chromosome Ia that is expressed in gametocytes only 
(green shading).  An additional third of intergenic introns can be attributed to unanno-
tated exons extending existing gene models (often as UTR exons), and most of the 
remaining third are associated with non-coding RNAs of unknown significance (and often 
inefficiently excised). 
		TgME49_chrIa:87,001..93,000 	Unannotated	Gene	
 
Figure 2.10.  Genome browser view of an unannotated gene. 
Genome annotation and selected RNA-seq tracks from tachyzoites and gametocytes.  Note that 
blue and red tracks are scaled logarithmically.  Arrows and circles indicate transcript termini.  Two 
tracks display candidate introns (brackets): the ‘filtered’ track is restricted to display only those 
introns that pass the abundance and efficiency criteria described in this thesis. 
 
Overall, the most common errors associated with existing annotation derive from 
inaccurate annotation of transcript termini, which are often stage-specific.  As noted 
above, this may impact intron usage, splicing efficiency, and the selection of translation 
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start sites.  In the absence of functional evidence, however, it is not necessarily clear 
that alternative starts and stops are biologically relevant, or should be annotated.  For 
example, the dynein heavy-chain family protein TgME49_309980 (Fig 2.11A) is a 63 
exon gene, spanning nearly 50 kb.  Despite low expression levels (FPKM <10), all 62 
introns appear to be accurately annotated, but tachyzoite stage-specific termini suggest 
a much shorter transcript in this stage, including exons XXXVII-LIII only (or perhaps XIX-
LXV), and lacking many domains likely to be essential for function.  From the available 
data (all based on steady-state RNA, as ribosomal profiling data is not yet available for 
T. gondii), it is unclear whether the different transcript termini inferred from tachyzoite vs 
gametocyte RNA-seq data reflect differences in transcriptional initiation and termination, 
or differences in mRNA stability and degradation, but chromatin marks provide some 
evidence in support of a shorter tachyzoite-specific transcript (not shown).  In addition, a 
tachzyoite-specific antisense RNA transcript (lncRNA; green box in Fig. 2.11) could 
potentially play a role in regulating mRNA stability (discussed further below). 
While most genes in the T. gondii genome are accurately annotated, and most high 
abundance unannotated introns are readily interpretable (as noted above), some genes 
will remain refractory to annotation without additional experimental data.  For example, 
TgME49_270520 (Fig 2.11B) encodes a ‘hypothetical protein’ of no known function that 
is most abundant in gametocytes but expressed in all life cycle stages except unsporu-
lated oocysts.  The current reference annotation includes 6 exons, but at least 2 addi-
tional exons are evident (green stars); analysis of intron-spanning reads suggests that 
exons IV-VII may be included in the mature mRNA in various permutations and combin-
ations, possibly using different combinatorial patterns in different life cycle stages. 
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A		TgME49_chrXI:941,001..991,000	 	TgME49_309980	(Dynein	Heavy	Chain	Family	Protein)	
B		TgME49_chrVIII:5,209,001..5,223,000	 	TgME49_270520	(HypotheKcal	Protein)	
 
Figure 2.11.  Genome browser view of alternatively-spliced transcripts that are difficult to 
confidently annotate. 
Genome annotation and selected RNA-seq tracks from tachyzoites and gametocytes.  Note that 
blue and red tracks are scaled logarithmically, while tracks shown in semi-transparent overlay are 
linear (also note different scales, selected to highlight alternative splicing).  Arrows & circles indi-
cate transcript termini, stars indicate variants discussed in the text.  Two tracks display candidate 
introns (brackets): the ‘filtered’ track is restricted to display only those introns that pass the abun-
dance and efficiency criteria described in this dissertation. 
 
Figure 2.12 reproduces Fig 2.6, highlighting the expression of annotated and 
unannotated introns for some of the alternatively-spliced genes discussed above.  Note 
that most annotated introns (closed circles) only overlap alternatives at implausibly low 
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abundance, i.e. they map to the upper left quadrant, while most unannotated introns 
(open circles) map to the lower right quadrant, i.e. they overlap annotated introns that 
are much more efficiently expressed and spliced. 
Annotated intron with Unannotated alternative
Unannotated intron with Annotated alternative 
Unannotated introns, Unannotated alternative
   HXGPRT introns (unannotated)
Rps15A introns
G6PDH introns
TgME49_270520
alternative  
Figure 2.12.  Identification of alternative-spliced introns.   
Maximum splicing efficiency (ISRPM/FPKM) for each putative intron vs its most prominent over-
lapping alternative intron (replica of Fig 2.6).  Black, annotated introns overlapping unannotated 
alternatives; Blue-gray, unannotated introns overlapping annotated alternatives; Gray, unanno-
tated introns overlapping unannotated alternatives.  Colored dots highlight introns associated with 
TgME49_200320 (HXGPRT; Magenta … see Fig 2.1), TgME49_234450 (Rps15a; Red … see 
Fig 2.7), TgME49_278830 (G6PDH; Turquoise … see Fig 2.9), TgME49_270520 (hypothetical 
protein; Orange … see Fig 2.11B). 
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Alternatively-spliced introns map to the yellow shaded area, including the two anno-
tated HXGPRT introns and the single unannotated cassette exon-spanning intron 
(magenta), the single annotated exon-spanning intron in Rps15A and the two unanno-
tated introns flanking the cassette exon (red), and both the annotated and unannotated 
splice acceptor variants for G6PDH (turquoise).  Additional annotated HXGPRT and 
G6PDH introns are efficiently spliced, but lack any alternatives, and are therefore off-
scale to the left.  Several unannotated G6PDH introns overlap the first annotated intron, 
within the 5’UTR (see Fig 2.9), and map to the lower right quadrant.  The first two 
TgME49_ 270520 introns are excised in all splice variants (see Fig 2.11B) and are 
represented by solid orange dots in the upper left quadrant, but other annotated and 
many unannotated introns combining cassette exons in various ways yield a diversity of 
introns displaying low apparent splicing efficiency. 
Figure 2.13 highlights stage-specific alternatively spliced introns, by comparing the 
intron excision efficiency (ISRPM/FPKM) of tachyzoites vs gametocytes.  For example, 
Isocitrate DH intron I (TgME49_266760; left-most green dot)  is inefficiently excised in 
gametocytes only because the gametocyte stage-specific promoter lies within the first 
intron (see Fig 2.8).  Many such intron isoforms map to UTRs, often incorrectly anno-
tated (as in this case).  Because only the central portion of TgME49_309980 (Dynein 
HC; see Fig 2.11A) is transcribed in tachyzoites, gene-level FPKM values are low, 
central introns appear to be excised with efficiencies >1, and introns outside this region 
appear to be excised unusually poorly (blue dots in Fig 2.13).  The unannotated intron 
acceptor variant in G6PDH (turquoise; see Fig 2.9A) is not observed in gametocytes 
(Figure 2.9B), and therefore lies on the vertical axis in Fig 2.13. 
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Annotated introns (diameter reflects max intron abundance)
Unannotated introns (diameter reflects max intron abundance)
>5X differential excision, filtered on expression (FPKM >1; both stages) and
maximum intron abundance (max ISRPM >1) … but not splicing efficiency
   HXGPRT introns (annotated, unannotated)
   Rps15A IsocitrateDH
   G6PDH DyneinHCFP
   TgME49_270520 introns
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Figure 2.13.  Identification of stage-specific alternative-spliced introns.   
The size of the dots in this panel reflects the maximal ISRPM observed in these samples.  Yellow 
highlights introns displaying FPKM values >1 in both samples, maximum intron abundance (in 
either sample) >1, and >5-fold differential intron excision efficiency between tachyzoites and 
gametocytes.  Introns labelled in magenta, red, turquoise and orange show no significant stage-
specificity in intron excision, except as noted in the text. 
Discussion 
A previous report has demonstrated the value of RNA-seq data for improving T. 
gondii genome annotation, including the recognition of alternatively-spliced isoforms 
(Hassan et al. 2012).  Because our preliminary analysis revealed that strand-specific 
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RNA-seq data is substantially more valuable for gene model assessment (cf. Fig 2.3), 
detailed studies of structural annotation and alternative splicing were carried out using 
the 20 highest quality, strand-specific datasets (total of >500M reads, including >60M 
intron-spanning reads; Table 1).  Results were then integrated with all available informa-
tion, including non-strand-specific and/or lower depth RNA-seq data(Lorenzi et al. 2016; 
Minot et al. 2012; Reid et al. 2012; Pittman, Aliota, and Knoll 2014; Hehl et al. 2015), as 
well as microarray (Fritz et al. 2012; Grigg et al. 2001; Behnke et al. 2014; Buchholz et 
al. 2011; Bahl et al. 2010), SAGE tag & EST studies (Radke et al. 2005), proteomics 
data (Xia et al. 2008), chromatin marks (Gissot et al. 2007), population-level sequence 
variation (SNPs; Lorenzi et al. 2016), etc.  These results were consistent with all 
previous reports on transcript variation, including alternative splicing of the HXGPRT 
locus (Fig 2.1; Donald et al. 1996; Chaudhary et al. 2005), and examples highlighted by 
Hassan et al. 2012. 
Overall, the accuracy of existing reference annotation is quite high: >93% of all 
annotated introns are supported by the pooled mRNA-seq datasets.  In aggregate, these 
samples define >2.7M intron junctions, but while almost all correspond to consensus 
intron boundaries and are therefore likely to be genuine, most are present at very low 
abundance (<<0.1 intron-spanning reads per million; ISRPM).  Establishing a minimum 
requirement of ISRPM >1 appears to be quite conservative, removing very few anno-
tated introns, but excluding the vast majority of unannotated introns (Figs 2.4-2.6, 
Additional File 1).  In addition, it is also helpful to exclude introns that are inefficiently 
excised (low ISRPM/FPKM ratios; also known as ψ (Percent Spliced In; Venables et al. 
2008), even if they are frequently observed in heavily transcribed genes.  Various 
statistical methods have been developed to improve the estimation of ψ (Katz et al. 
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2010; Shen et al. 2014; Trapnell et al. 2013; Vaquero-Garcia et al. 2016), but 
ISRPM/FPKM serves as an adequate proxy when gene annotation is close to accurate, 
and is easier to automatically extract from RNA-seq mapping pipelines and genome 
databases.  Assuming that the current T. gondii annotation provides a reasonable 
approximation of the truth, with little systematic bias, setting the minimum excision 
efficiency at 20% minimizes false discovery (Fig 2.6, Fig S1) … although of course some 
less frequent isoforms may still be functional, or may be observed at higher frequency 
under as-yet-untested conditions. 
Plotting intron frequency vs transcript abundance clearly distinguishes introns that 
are always excised from those that are alternatively spliced, and those with low pene-
trance that are unlikely to yield biologically-functional transcripts (Fig 2.4; see HXGPRT 
as a positive control; Uhlén et al. 2015).  Most of the putative false positives in this 
example are in fact expressed in other life cycle stages (Table 2, Fig 2.5A). Defining 
each intron based on the sample providing maximum support permits identification of 
>93% of all annotated introns (Table 2, Fig 2.5B).  A modest number of annotated 
introns (2693) have no support and should probably be removed from the official anno-
tation, and a similar number (2847) should be added, either as novel introns (1239), or in 
conjunction with other unannotated introns (204), secondarily to an annotated intron 
(966), as the preferred isoform (274), or in a few cases replacing an annotated intron 
(164).  Plotting ISRPM/FPKM ratios in reference introns vs the most prominent alterna-
tive isoform (if one exists) provides a more sensitive means for discriminating alterna-
tively-spliced introns (Figs 2.6, 2.12 & 2.13).  These criteria are readily automated, 
permitting application to many incompletely annotated genomes.  For example, the 
filtering characteristics based on those described above have recently been imple-
	
57	
	
mented in ToxoDB build 29 (compare the two intron tracks presented in Figs 2.7-2.11 
with minimally-filtered splice junction data in Figs 2.1 & 2.3), and appear applicable to 
Plasmodium falciparum as well (see Chapter 4). 
Case studies reveal the same assortment of incomplete annotations observed in 
other eukaryotes (Mudge and Harrow 2016; Hassan et al. 2012), including UTR infor-
mation, missing exons (especially at transcript termini), and the usual assortment of 
splice variants: alternative splice donors, splice acceptors, exon-skip variants, unexcised 
introns, etc (Figs 2.7-2.11).  A plethora of overlapping but inefficiently spliced introns 
suggests multiple promoters, frequently associated with a UTR (cf. Figs 2.7, 2.8 & 2.9), 
and often resulting in mis-annotation of the most probable translational start (ATG).  
Indeed, it seems likely that improper ATG annotation constitutes the most biologically-
relevant source of errors in current T. gondii annotation, as accurate definition of the 
mature N-terminus has important implications for subcellular localization predictions, and 
trafficking is particularly important for mediating pathogen interactions with their host 
cells.  The sequence context of T. gondii initiation codons is known to be highly 
constrained (Matrajt et al. 2004), providing a basis for systematic improvement of CDS 
annotation.  UTR predictions could also be improved substantially by using a less greedy 
algorithm to select the most abundant UTR(s), rather than the longest (cf. Fig 2.7).  
Similarly, gene annotations that incorporate the most abundant introns, rather than the 
one that results in the longest open reading frame, as is currently the case, would yield 
more accurate gene models.  Additional evidence based on chromatin marks (Gissot et 
al. 2007) and proteomics studies (Xia et al. 2008) can provide further support for (or 
refutation of) candidate gene models, but ultimately, there is no substitute for biologists 
understanding and being able to interpret the underlying data.  Without additional 
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experimental evidence, it is unlikely that any algorithm will be able to accurately annotate 
biologically significant transcriptional start sites for TgME49_288830 (Fig. 2.9), or sensi-
ble structural models for TgME49_270520 (Fig. 2.11B), 
In the absence of gene assignments (and therefore FPKM values), evaluation of 
introns that map outside annotated genes is more difficult, but this problem could be 
addressed by using local analyses (Katz et al. 2010; Shen et al. 2014; Trapnell et al. 
2013; Vaquero-Garcia et al. 2016).  On the order of 300 protein-coding genes appear to 
be missing from the current annotation, but now that data is available for most life cycle 
stages, it is likely that many could be identified by re-running de novo gene predictors, 
informed by newly available RNA-seq datasets.  This would be especially true since 
current de novo gene finders have used evidence exclusively from the tachyzoite stage 
and genes expressed in other non-tachyzoite stages have been predicted based on ab 
initio gene finders only.  Other transcripts evident within intergenic regions (both with and 
without introns) may highlight long non-coding RNAs.  Defining these lncRNAs has 
proved difficult however, as gene finders cannot rely on the same sequence features 
known to be useful for protein coding genes. 
	
59	
	
CHAPTER 3:  MECHANISMS OF TRANSCRIPTIONAL REGULATION IN 
TOXOPLASMA GONDII (Adapted From Paper) 
 
The development and dissemination of low-cost technologies for deep sequencing 
of RNAs has yielded many new insights (Wang, Gerstein, and Snyder 2009).  mRNA-
seq provides experimental evidence for genome annotation, enabling identification of 
differentially-spliced transcript isoforms, and previously-unrecognized coding and non-
coding RNAs, as described in Chapter 2 (Mudge and Harrow 2016), while also providing 
a comprehensive, quantitative picture of transcript diversity.  Whole transcriptome profil-
ing of various cells and tissues, under diverse conditions, permits the identification of 
tissue / lineage / stage / strain-specific signatures (Uhlén et al. 2015), which can be used 
to construct metabolic and physiological models (de Oliveira Dal’Molin et al. 2016), 
examine complex samples such as pathogen-infected tissues (Westermann, Gorski, and 
Vogel 2012), etc. 
Although comparing global gene expression patterns was not the primary goal of 
this study, we have generated and sequenced 24 strand-specific RNA libraries from 
several developmental stages/strains, as noted above, and examined these in conjunct-
tion with 45 additional libraries (Table 1).  In aggregate, this provides the most compre-
hensive collection of data available on T. gondii transcript abundance across the para-
site life cycle.  Overall, transcriptomic results are highly consistent with biological and 
phenotypic variation across the complex parasite life cycle (Fig 1), including previously 
undescribed differences in gene expression during intracellular tachyzoite replication.  
Strong circumstantial evidence also suggests that lncRNAs may play an important role in 
regulating stage-specific expression during sexual differentiation and sporogony. 
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Methods 
Data analysis and visualization 
FPKM values for all genes (8,920 rows in Additional File 3) in the T. gondii genome 
(ToxoDB version 28) were filtered to restrict to those with FPKM value ≥ 20 (5,645 
genes) for PCA and MDS analysis using the statistical excel add-in XLSTAT (Addinsoft; 
Figs 3.1, 3.2).  Pearson (n) standardization was used for PCA, between-sample proxi-
mity matrices were calculated from the factor scores based on Euclidean distances.  For 
MDS, we used the proximity matrix from PCA factor scores and selected the absolute 
model, Kruskal's stress, random initial configuration, 10 repetitions and stopped condi-
tions if convergence was equal to 10-5 with > 500 iterations. 
Results 
Stage-specificity of T. gondii gene expression 
RNA-seq datasets in this study were exploited to examine how global gene expres-
sion patterns compare across the parasite life cycle, from the acutely lytic tachyzoites 
responsible for disease, to latent bradyzoite tissue cysts in the brain, to sexual stage 
gametocytes from feline intestinal epithelium, to unsporulated oocysts in the environ-
ment (the fertilized zygote), and finally to the sporulated meiotic progeny (sporozoites) 
that are the immediate precursors to reinitiation of tachyzoite infection (Dubey, Lindsay, 
and Speer 1998).  Additional File 3 presents FPKM values for the entire T. gondii 
genome for the 20 high quality strand-specific RNA-seq experiments highlighted in Table 
1.  Sample-specific correlations were performed using all genes that are expressed at 
FPKM >20, in any sample (63% of the genome). 
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Principal component analysis (PCA) clearly separates major life cycle stages, corre-
lating well with parasite biology (Table 3).  PC1 accounts for 27% of variation, and read-
ily distinguishes oocysts (both sporulated & unsporulated) from gametocytes from asex-
ual stages (both tachyzoites & bradyzoites).  PC2 (23%) distinguishes gametocytes and 
unsporulated oocysts from tachyzoites/bradyzoites & sporozoites (see Fig 3.1 for a plot 
of PC1 vs PC2).  PC3 (12%) distinguishes sporulated vs unsporulated oocysts; PC4 
(11%) appears to distinguish early vs late stage tachyzoites.  PC5 (8%) distinguishes 
mature bradyzoites from other stages.  Overall, the top 10 principal components explain 
~97% of observed variation between the 20 samples included in this study.  
 
PC#1 PC#2 PC#3 PC#4 PC#5 PC#6 PC#7 PC#8 PC#9 PC#10 PC#11 PC#12 PC#13 PC#14 PC#15 PC#16 PC#17 PC#18 PC#19
Sample 26.7% 23.1% 11.7% 11.4% 7.9% 5.2% 3.2% 2.5% 2.2% 1.9% 1.3% 0.8% 0.6% 0.4% 0.4% 0.3% 0.2% 0.2% 0.1%
2Tz4_S 2.19 %7.25 %6.61 %30.09 %6.83 %7.90 9.04 %8.55 1.59 7.64 %7.86 %12.79 11.27 5.91 6.58 %4.84 %3.95 %2.86 2.16
2Tz8_S 0.10 %2.53 %10.32 %40.55 %6.02 9.59 9.17 %11.19 %2.37 11.83 5.23 4.47 %8.81 9.24 1.99 1.26 8.95 0.18 0.51
2Tz16_S 8.98 %6.85 %13.13 %23.12 %6.66 16.35 5.56 %6.32 %4.15 14.02 5.10 %4.66 %7.66 %2.60 %3.75 5.41 %8.95 %0.38 %4.31
2Tz36_S 17.30 %24.59 %20.85 24.36 %10.83 15.77 %14.32 %0.59 %4.53 22.11 0.12 %3.09 9.36 %6.90 %4.54 2.55 3.87 2.56 3.51
2Tz44_S %6.02 %39.66 %6.37 28.90 %7.18 %31.17 %7.82 %16.98 5.77 10.07 %15.66 9.34 %7.81 %3.22 1.85 %4.65 %0.82 %0.32 %1.51
3Tz2_S %12.63 %16.70 0.38 %31.60 %6.33 %19.12 %0.25 3.57 %0.65 %13.73 %10.33 %4.24 %0.04 %4.01 %9.42 5.28 3.57 %6.48 0.64
3Tz4_S %2.51 %9.89 %4.36 %29.76 %5.55 %14.40 6.65 7.10 %1.62 %9.72 %6.60 %4.64 4.36 %2.80 1.34 0.10 2.58 9.39 %4.49
3Tz8_S %6.73 %2.59 %6.15 %39.26 %7.96 1.29 1.27 2.64 %4.23 %5.12 6.63 21.71 8.20 %4.88 4.25 1.03 %3.33 %0.81 1.73
3Tz16_S 13.63 %11.03 %12.92 %11.98 %5.74 11.25 4.34 16.31 %4.77 %6.47 5.95 %5.85 %11.55 %7.95 1.16 %9.82 %0.01 %0.17 3.28
3Tz36_S 12.28 %30.15 %19.75 26.70 %10.04 5.90 %16.26 19.07 %7.39 %1.76 6.74 0.19 4.39 4.26 3.90 %1.99 2.48 %4.78 %6.17
3Tz44_S 2.45 %32.92 %12.67 16.52 %6.96 %11.99 %14.15 14.79 %5.28 %8.21 %2.25 0.50 %5.33 10.84 %0.29 5.15 %4.66 3.35 4.51
TzHl_S 32.43 %17.53 %20.24 31.37 7.61 43.44 20.63 %10.34 9.21 %17.42 %12.11 3.56 1.74 1.87 %1.37 0.09 %0.10 0.03 %0.14
2Bz_S %7.52 %37.88 %4.15 26.31 7.33 %23.26 9.93 %19.12 10.88 %10.62 25.14 %4.68 2.15 %1.27 %0.43 1.08 0.41 0.31 0.50
3Bz_S 3.09 %15.04 14.70 %8.85 88.10 0.27 %6.81 2.95 %6.46 4.41 %1.62 0.32 0.26 %0.21 0.34 %0.23 0.03 %0.14 %0.08
3dGmt_S 47.67 42.95 17.16 %13.70 %1.23 %2.71 %10.76 8.95 29.93 5.03 3.79 3.82 2.12 4.41 %8.80 %4.76 %1.07 0.82 %0.64
5dGmt_S 57.46 71.09 22.67 17.60 %7.87 %9.24 %0.86 %14.92 %30.61 %6.23 1.38 1.00 1.33 1.93 %4.33 %2.86 %0.34 0.35 %0.20
7dGmt_S 64.73 56.80 20.19 14.50 %1.92 %6.05 %0.06 5.77 11.79 0.72 %2.43 %3.52 %3.79 %5.10 11.19 7.46 1.45 %1.28 0.67
Sz0_S %100.83 95.82 %54.20 16.31 9.16 %1.18 %3.15 0.18 3.29 %0.85 %0.65 %0.87 %0.39 %0.14 0.03 %0.04 %0.06 %0.01 0.02
Sz4_S %71.11 %8.19 64.70 %5.59 %14.00 27.07 %26.84 %12.17 2.74 %7.84 %0.12 %3.27 %1.00 %0.53 2.33 %0.41 %0.05 0.59 %0.09
Sz10_S %54.96 %3.87 51.91 31.93 %7.08 %3.93 34.69 18.85 %3.15 12.15 %0.44 2.70 1.19 1.15 %2.02 0.18 %0.01 %0.34 0.09 
Table 3.  Analysis of stage-specific gene expression patterns in T. gondii by Principal 
Component Analysis. 
Principal Component Analysis (PCA) for the 20 high quality strand-specific RNA-seq samples 
defined in Table 1, using all genes that are ever expressed at FPKM >20, in any sample.  Contri-
butions of each sample to the first 10 principal components, accounting for ~97% of observed 
variation. 
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Figure 3.1.  Spatial 
distributions of stage-
specific gene expression 
patterns by PCA analysis.   
First two principal compo-
nents for all samples, colored 
to highlight tachyzoites 
(green), bradyzoites 
(orange), gametocytes (red), 
unsporulated oocysts 
(magenta) & sporulated 
oocysts (purple). 
 
 
See Additional File 3 for further details including eigenvalues, sample correlations, 
lists of specific genes making the greatest contribution to these principal components, 
eigenvectors for all genes, and the results of other analyses (K-means clustering, agglo-
merative hierarchical clustering, hierarchically-clustered expression heat maps, etc).  
Little is known about the specific genes or mechanisms involved in sexual differentiation 
in Toxoplasma, so it is difficult to compare these results with prior knowledge, but brady-
zoite differentiation has been studied extensively (Dzierszinski et al. 2004; Soete, 
Camus, and Dubremetz 1993; Singh, Brewer, and Boothroyd 2002), and it is reassuring 
to find that major contributors to PC5, which clearly distinguishes mature bradyzoites 
from other stages, include the known bradyzoite differentiation markers BAG1, LDH2, 
ENO1, SRS9, SRS35A & SRS35B (Wasmuth et al. 2012; Dzierszinski et al. 2001). 
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Fig 3.2 uses multidimensional scaling (MDS; Hout, Papesh, and Goldinger 2013) to 
more accurately reflect between-sample distances in two dimensions (although the axes 
themselves are meaningless), particularly for various strains and stages of tachyzoites, 
which are not well-distinguished by PC1 & 2.  Note that all 12 tachyzoite samples group 
together (green cloud), despite representing three strains, including the canonical type II 
& III lineages (green & blue dots, respectively; Howe and Sibley 1995; Grigg et al. 2001), 
and various early to late time points during intracellular replication.  Additional analysis 
(not shown) demonstrates that type I strain tachyzoites co-cluster as well.  In vitro brady-
zoites (2Bz_S) cluster with tachyzoites (although in the direction of mature bradyzoites 
isolated from murine brain cysts; 3Bz_S, orange), as expected given the long, slow pro-
cess of tachyzoite-to-bradyzoite differentiation (Dzierszinski et al. 2004; Soete, Camus, 
and Dubremetz 1993).	 
Figure 3.2.  Spatial distribu-
tions of stage-specific gene 
expression patterns by MDS 
analysis.   
MDS of the same samples; 
note that for tachzyoites, samples 
group based on time post-
infection (hr 2, 4, 8 …) rather 
than parasite strain 
(2Tz=ME49, 3Tz=VEG) 
 
 
 
 
Gametocytes (red), unsporulated oocysts (magenta), and sporulated oocysts 
(purple) are also readily distinguished, justifying the binning of these samples, as shown 
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in Fig 3.3 (green and blue dots represent tachyzoites samples binned by strain; black dot 
represents pooled data for all T. gondii tachyzoite samples). 
Figure 3.3.  Spatial distri-
butions of stage-specific 
gene expression patterns 
by MDS analysis binned by 
stage and strains.   
MDS for samples binned 
samples by stage and strain. 
 
 
 
 
 
It is interesting to note that tachyzoite samples from similar time points post-infec-
tion are often more similar to each other than early vs late time points from the same 
strains in Fig 3.2, i.e. the 8 hr post-infection samples of ME49 vs VEG parasites (2Tz8 & 
3Tz8) are relatively similar to each other, as are 36 & 44 hr time points. In contrast, 
ME49 strain 8 & 36 hr time points are quite distinct, as are VEG strain 8 & 36 hr time 
points. PCA analysis of samples binned based on time post-infection (Fig 3.4) shows 
that PC1 & 2 account for >76% of the observed variance. 
Principal component 1 (PC1) does a good job of stratifying samples based on early 
vs late infection, and the top indicators are slightly enriched in genes associated with 
intracellular trafficking (P<10-3); PC2 correlates with intracellular vs extracellular tachy-
zoites, and is enriched in genes bearing GO terms associated with redox balance and 
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chromatin assembly (P<10-3).  Functional distinctions over the course of intracellular 
tachyzoite infection have not been extensively studied, but analysis of genomic-scale 
expression profiles provides unprecedented resolution.  These results also resonate with 
anecdotal observations of other differences, such as changes in splice site selection 
during the course of intracellular growth (Fig 2.9). 
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Figure 3.4.  Spatial distributions of tachyzoite-specific gene expression patterns by PCA 
analysis binned by time post-infection. 
PCA for tachyzoite samples binned based on time post-infection. 
A role for opposite strand transcripts in regulating stage-specific expression? 
As noted above, in addition to protein-coding genes, long non-coding transcripts 
(lncRNAs; Patil et al. 2013) are also observed T. gondii RNA-seq datasets, and circum-
stantial evidence suggests a possible role in transcriptional regulation.  For example, the 
location of tachyzoite-specific lncRNAs in Figs 2.3 & 2.11A (green boxes) suggests that 
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they may act to suppress (or degrade) full-length mRNAs on the opposite strand.  A 
quick search of the T. gondii database for genes with abundant support for sense-strand 
transcription in tachyzoites and antisense transcription in gametocytes yields dozens of 
genes, including several AP2-family transcription factors (Walker, Gissot, Huot, et al. 
2013; Walker, Gissot, Croken, et al. 2013; Grigg et al. 2001; Behnke et al. 2014; Hehl et 
al. 2015).  As shown in Fig 3.5A, there is a strong inverse correlation between expres-
sion of TgME49_282210 (AP2-VIIA8) mRNA in tachzyoites but not gametocytes, and 
opposite strand transcription in gametocytes but not tachzyoites.  A similar inverse 
relationship was also observed for mRNA expression in bradyzoites and sporozoites, 
and lncRNA transcription in oocysts (not shown, but see Additional File 4).  Neither 
stage-specific differences nor opposite strand transcripts were detected in the adjacent 
gene (TgME49_282210), which is also a putative AP2 transcription factor (AP2-VIIA9).  
Further inspection reveals a similar sense and antisense transcription patterns for many 
other genes in the parasite genome (Fig 3.5B). 
To further explore the relationship between mRNAs and opposite strand lncRNA 
expression genome-wide, sense vs antisense transcript abundance was examined for 
various pairwise sample comparisons.  Comparing tachyzoites with gametocyte samples 
(Fig 3.6) shows that the vast majority of genes are similarly expressed (central black 
cloud), consistent with observations in Table 2A.  Some genes display stage-specific 
expression, with steady-state levels that differ by up to 105-fold.  Positive controls for 
tachyzoite-specific, gametocyte-specific, and constitutively expressed genes are 
indicated in red, purple and green, respectively).  The size of datapoints are scaled to 
reflect maximum mRNA abundance for the comparisons shown (FPKM values), i.e. 
large dots reflect abundant transcripts (ribosomal RNAs are indicated in gray). 
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A		TgME49_chrVIIa:4,450,001..4,468,001 	TgME49_282210	(AP2-VIIA8)	
 
B		TgME49_chrIb:1,721,501..1,728,000	
 
Figure 3.5.  Selected examples of genes displaying an inverse stage-specific correlation 
between antisense RNA and mRNA. 
Top:  Gametocyte vs Tachyzoites.  mRNA for TgME49_282210 (encoding AP2-VIIA8; left) is 
expressed on the reverse (red) strand in tachyzoites, while overlapping lncRNA is transcribed on 
the forward (blue) strand in gametocytes (see also reciprocal arrangement in Figs 2.3 & 2.11A).  
Note that the adjacent functionally-related gene (TgME49_282220 = AP2-VIIA9; at right) is 
constitutively expressed, with no antisense transcription.  Bottom: Oocysts vs Tachyzoites.  
Tachyzoite-specific mRNA (TgME49_321590) and overlapping lncRNA on the reverse strand in 
gametocytes (left); the adjacent tachzyoite- and oocyst-specific mRNAs (TgME49_321570 & -
321580, respectively) are convergently transcribed, with long overlapping 3’UTRs (right). 
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Figure 3.6.  Antisense RNAs are inversely correlated with stage-specific mRNA transcript 
abundance during T. gondii differentiation. 
The ratio of tachyzoite/gametocyte expression on the mRNA sense-strand (horizontal) vs anti-
sense expression (vertical), for all annotated genes in the T. gondii genome. Points are scaled to 
reflect maximal mRNA abundance for the two samples represented in each graph; shading 
indicates excess antisense/sense strand expression in tachyzoites (orange) or gametocytes 
(blue); gray denotes ribosomal transcripts.  For example, the yellow star at center/left 
corresponds to the transcription factor AP2-VIIA8 (TgME49_288210), which is abundantly 
transcribed on the sense strand in gametocytes, and overlaps a tachyzoite-specific lncRNA on 
the opposite strand (left part of Fig 3.5A); X's indicate transcripts known to be constitutive (actin, 
alpha-tubulin1, histone H3.3, Asp1, calmodulin; green), or specific to tachyzoites (SAG1, GRA1, 
MIC1, ROP15, ENO2; red), gametocytes (SRS12A, SRS15A, SRS22B-1&2, SRS37B; purple) 
 
Antisense transcription is generally less abundant than mRNA (cf. Fig 2.11), and 
less variable between samples, but differences of up to 103-fold are observed for some 
genes.  In gametocytes, these is a slight correlation between sense and antisense 
expression, resulting in a positive overall slope, especially in the right half of Fig 3.6.  
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Shading reflects an overabundance of antisense transcript relative to the mRNA, i.e. 
tachyzoite-specific mRNA transcripts associated with gametocyte-specific antisense 
transcription (such as TgME49_282210; Fig 3.5A) are shaded blue. 
Conversely, many gametocyte-specific genes (at right) are transcribed on the oppo-
site strand in tachyzoites (orange shading).  These differences are even more evident in 
comparisons of tachyzoites with parasite oocysts (Fig 3.7).  More genes are differentially 
transcribed in tachyzoites vs unsporulated oocysts, and a slightly wider range of anti-
sense transcript ratios is also observed (there was no discernable correlation between 
sense and antisense transcription within these tachyzoite or oocyst experiments) .  More 
tachyzoite-specific genes display excess antisense transcription in oocysts, and the 
majority of unsporulated oocyst-specific transcripts are correlated with tachyzoite-
specific antisense transcription.  Three intriguing examples are highlighted in Fig 3.5B: 
TgME49_321590 (an uncharacterized ‘hypothetical protein’) is transcribed on the mRNA 
(sense, blue) strand in tachyzoites (as well as bradyzoites & gametocytes; not shown), 
and on the opposite (antisense, red) strand in unsporulated oocysts (and sporozoites; 
not shown).  The adjacent genes TgME49_321580 (a putative membrane protein) and 
TgME49_321570 (FabZ) are also stage-specifically expressed, in either unsporulated 
oocysts only (TgME49_321580) or tachyzoites (TgME49_321570).  Interestingly, these 
genes are convergently transcribed, with 3’ UTRs that overlap extensively, providing the 
potential for antisense-mediated regulation based on mRNAs rather than lncRNAs. 
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Figure	3.7.		Antisense	RNAs	are	
inversely	correlated	with	stage-
specific	mRNA	abundance	during	T.	
gondii	differentiation.		 
(A) tachyzoites vs unsporulated 
oocysts, (B) d4 sporulated oocysts, 
(C) d10 sporulated oocysts.  Points 
are scaled to reflect maximal mRNA 
abundance for the two samples 
represented in each graph; shading 
indicates excess antisense/sense 
strand expression in tachyzoites 
(orange) or oocysts (blue); gray 
denotes ribosomal transcripts.  For 
example, the yellow star at far right 
in panel A corresponds to Oocyst 
Wall Protein 2 (TgME49_209610), 
which is abundantly transcribed on 
the sense strand in oocysts, and 
overlaps a tachyzoite-specific 
lncRNA on the opposite strand; other 
yellow stars correspond to the three 
genes in Fig 3.5B.  'X's indicate 
transcripts known to be constitutive 
(actin, alpha-tubulin1, histone H3.3, 
Asp1, calmodulin; green), or specific 
to tachyzoites (SAG1, GRA1, MIC1, 
ROP15, ENO2; red), oocysts 
(OWP2, TBPIP, RAD54, 
TgME49_249520 & 263010; blue), or 
sporozoites (MIC13, SRS28, 
TgME49_209920, 259900 & 276880; 
turquoise). 
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Samples isolated after the induction of sporulation provide the opportunity to follow 
changes in sense and antisense transcript abundance during differentiation.  Day 4 
sporozoites (Fig 3.7B) are much more similar to tachyzoites, and day 10 sporozoites 
even more so (Fig 3.7C). i.e. the cloud of transcription ratios becomes progressively 
tighter.  Importantly, antisense transcripts also change in parallel with this change in 
transcriptional profile, as oocysts differentiate into the sporozoites that will transform into 
tachyzoites once they infect a host cell: orange dots become less prominent, as oocyst 
genes (with tachzyoite-specific antisense transcripts) are downregulated, and the blue 
dots essentially vanish, as the antisense RNAs to tachyzoite-specific mRNAs that were 
abundant in oocysts disappear during the course of sporozoite differentiation. 
Discussion 
At least 69 RNA-seq samples are currently available for T. gondii parasites, many of 
which are described here for the first time (Table 1).  Considered in their entirety, these 
studies sample strain diversity (Hassan et al. 2012), the intracellular tachyzoite replica-
tive time course, and most major life cycle stages.  Expression profiling has been used 
to investigate developmental signatures in many systems (Uhlén et al. 2015), and it is 
not surprising that major developmental stages can readily be distinguished (Table 3 & 
Figs 3.1 -3.4).  Results obtained from these analyses are consistent with previous analy-
ses of individual genes, and array-based transcriptional profiling (Fritz, Buchholz, et al. 
2012; Wasmuth et al. 2012; Buchholz et al. 2011; Radke et al. 2005; Bahl et al. 2010).  
Given their substantial biological differences, it is gratifying to observe that differences 
between life cycle stages are much larger than differences between strains (Fig 3.2).  
The relatively low cost of RNA-seq allows analysis of multiple samples, including time 
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course studies, and the high degree of resolution provided by strand-specific RNA-seq 
identifies reproducible differences even within the 48 hr intracellular tachyzoite repli-
cative cycle, which has not previously been reported (Fig 3.3, Fig S6).  In this regard, it 
is interesting to observe consistent differences in transcript splicing (Fig 2.9B, Fig S6), 
although the biological significance (if any) of these isoforms is not known. 
It is also clear that transcripts need not be restricted to mRNAs, as hundreds of 
lncRNAs are evident in the T. gondii genome, often overlapping stage-specific mRNAs, 
and reciprocally expressed (Figs 2.3, 2.11A & 3.5).  Some lncRNAs span the opposite 
strand gene (Fig 3.5), while others cover only a small portion (Figs 2.3 & 2.11A).  In 
other cases, stage-specific expression of convergently-transcribed genes yields long 
3’UTRs providing antisense coverage (Fig 3.5B, right).  Inversely correlated sense and 
antisense transcripts are most prominent in comparisons of tachyzoites with oocysts (Fig 
3.7), followed by tachyzoites vs gametocytes (Fig 3.6).  There is little evidence for anti-
sense association with the developmental transition from tachyzoites to bradyzoites (not 
shown, but see Additional File 4).  The inverse correlation between sense and antisense 
RNA abundance suggests a causal relationship, and it is tempting to rationalize these 
observations by imagining that the tight regulation of transition to gametocytes (in the cat 
gut), and oocysts (whose metabolism is very different, and must survive for months in 
the harsh external environment), could explain the use of non-transcriptional mechan-
isms for silencing.  Evaluating such hypotheses will require experimental testing, ideally 
using an in vitro model of the coccidian cycle in the definitive host. 
The nature of lncRNAs is not entirely clear in T. gondii and other apicomplexan 
parasites: PCR amplification of putative lncRNAs has not always been reliable, suggest-
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ing the possibility of multiple shorter transcripts rather than one long transcript; upstream 
sequences are not always effective as promoters in reporter assays; lncRNAs are not 
generally associated with active or repressive chromatin marks; and it is not even certain 
that T. gondii lncRNAs are all polyadenylated Pol II transcripts.  T. gondii does possess 
Argonaut and Dicer proteins, but it is not clear that these mediate silencing (Meissner et 
al. 2007; Crater et al. 2016).  It would be very helpful to have more effective methods for 
lncRNA prediction, but such algorithms have proved difficult to develop, and are not 
broadly applicable across diverse species (Fiscon, Paci, and Iannello 2015; Liao et al. 
2011).  By definition, coding potential is not relevant for assessing non-coding RNAs, 
and many lncRNAs display evidence of multiple introns that are very inefficiently excised 
(cf. Fig 3.5).  
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CHAPTER 4:  SUMMARY, GENERAL DISCUSSION AND FUTURE DIRECTIONS 
	
Structural annotation of gene models has been a challenge since the early days of 
genome sequencing, and has engaged both molecular biologists using experimental 
methods (RT-PCR, EST sequencing) and computational biologists responsible for ab 
initio and de novo methods.  Deep sequencing of RNA molecules has revolutionized 
gene prediction, as it is now possible to obtain hundreds of millions of short RNA (or 
polyA+ mRNA) reads from individual samples.  RNA-seq reveals an immense number of 
splice junctions, however, making it difficult to distinguish functional mRNAs from splic-
ing machinery errors and experimental artifacts.  Distinguishing alternatively spliced 
isoforms that that are likely to be functional and should be annotated, from those that 
should not, is an important unsolved problem. 
In order to study the prevalence of alternative splicing, we analyzed transcript 
expression from all available RNA sequencing experiments for the protozoan parasite 
Toxoplasma gondii, which displays typical eukaryotic splicing.  This species’ genome is 
substantially smaller than that of humans and most common model organisms: ~65Mb, 
encoding 8322 protein coding genes, with 40,103 annotated introns.  Several alterna-
tively-spliced genes have previously been characterized in T. gondii, including examples 
of intron retention, exon-skip polymorphisms, and splice acceptor and donor variants … 
providing positive controls for this analysis (Fig. 2.1).  There is also good reason to 
believe that algorithms used to identify alternative splice products in T. gondii will be 
applicable to other systems, as human nuclear extracts can properly splice T. gondii 
primary mRNAs, and vice versa. 
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Gene annotation 
Taken together, this work outlines effective strategies for exploiting RNA-seq data-
sets to improve the annotation of draft eukaryotic genomes.  New RNA sequencing tech-
nologies provide high depth, high quality transcriptomic evidence from entire genome(s), 
which has proven to be extremely valuable for improving annotation, and revealing 
unappreciated transcripts (Djebali et al. 2012; Harrow et al. 2012; Mudge and Harrow 
2016). 
The aggregate pool of RNA-seq data for all samples initially considered in this study 
(Table 1) provides considerable information: the observed total of >2.7 million reproduc-
ibly-observed introns expands the number of T. gondii  transcripts by many fold.  Most of 
these junctions are exceedingly rare, however, as they were observed fewer than six 
times in the total of 69 possible samples.  Furthermore, many of these rare junctions 
usually lie in non-coding regions such as UTRs (Fig 2.1) and lncRNAs and this is not 
surprising as higher sequence variation is known to be present in less conserved non-
coding sequences than in coding sequences (Mu et al. 2011; Castle 2011). 
The current T. gondii genome annotation was used as a guide to define parameters 
that minimize false discovery of transcripts.  Exploiting the relationship between the 
abundance of reads that span introns or ISRPM and the reads that map to annotated 
genes or FPKM (to which the introns map to), provided good separation between True 
Positive (black datapoints in upper half of Fig. 2.6) and True Negative introns (black 
numbers in the right-hand column of Table 2A), even when applied to other life cycle 
stages (Table 2A and Fig 2.7A) and other species (Neospora, Plasmodium; same para-
meters were applied to genomes in EuPathDB.org).  Introns with low ISRPM/FPKM are 
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inefficiently spliced and can be excluded from further analysis even if they are frequently 
observed in heavily transcribed genes.  An even better strategy is to directly compare 
intron abundance to the number of reads in the flanking exons of each intron, instead of 
using the expression of the entire gene to which the intron maps to.  Several other 
methods use ψ  or Percent Spliced In to study the prevalence of alternative splicing 
across transcriptomes (Venables et al. 2008; Katz et al. 2010; Shen et al. 2014; Trapnell 
et al. 2013; Vaquero-Garcia et al. 2016).  These alternative methods are aware of the 
change in coverage that can occur in a gene, if the gene is misannotated for example, 
and that is usually masked out by the fact that the total number of reads that map to a 
gene are normalized by the length of the gene, even if the coverage is not uniform in 
different exons of the same gene.  Despite these differences, the method described here 
serves as an adequate heuristic when existing genome annotation is close to accurate.  
This method is also relatively straightforward to implement, as it is relatively straightfor-
ward to automatically extract from RNA-seq mapping pipelines and genome databases.  
This method could be easily applied to other organisms for which similar databases are 
available. 
We found that best proportion of TP to TN introns occurred when we considered the 
maximal ISRPM from the 20 high quality samples selected in this study (Table 1) and 
compared it to the FPKM of the same sample where the maximal ISRPM was expressed 
(Table 2A and Fig 2.7B).  This analysis showed that most False Positive introns individu-
ally analyzed in different samples turned out not be real FP introns: many were stage-
specifically expressed (Fig 2.7B) and some were real alternatively-spliced isoforms (Fig 
2.8).  Likewise numerous False Negative introns were not completely false as they were 
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alternatively-spliced, but were less abundant than the annotated TP alternative (Table 
2B).  
In summary, we show that >93% of ~40K annotated introns associated with ~9K 
genes in the reference genome are strongly supported by RNA-seq data from at least 
one sample, leaving ~5% that should be deleted, and 2% that should be supplanted by 
alternative introns.  In addition, we describe ~20% well-supported new introns, including 
4% that are alternatively-spliced (many within UTRs), ~8% that modify existing gene 
models, and ~8% associated with novel transcripts (approximately equally divided 
between predicted mRNAs and lncRNAs).  Abundant introns associated with novel 
transcripts represent either genes that are specifically expressed in previously under-
studied stages (cf. Figure 2.5) or lncRNAs whose exact function is not known, but 
thought likely to be involved in transcriptional regulation (cf. Figs. 3.5-7). One of the 
difficulties in the current annotation is the definition of UTR boundaries, as the algorithms 
that were used for calling UTRs applied RNA-seq data in a greedy manner.  Instead of 
using the most abundant transcript to define UTR boundaries, the algorithm incorporated 
information from the longest possible transcript.  This means that a portion of annotated 
gene models have potentially long UTRs, sometimes affecting correct call of transcrip-
tional and/or translational start sites (cf. Figs 2.7-9).  Usage of the most abundant trans-
cript from RNA-seq data instead of the longest, should correct this problem in principle.  
However, as shown in Figure 2.8, this solution is difficult to implement as a general rule 
in all annotated genes.  For example, in the case of Isocitrate Dehydrogenase (Fig 2.8) it 
would result in exclusion of the first annotated intron, which is clearly excised more 
frequently in a stage-specific manner in tachyzoite parasites.  This intron is less often 
excised in the cat enteroepithelial stages because there is a stronger promoter within 
	
78	
	
this intron that would preclude excision most of the time.  It is difficult to decide which 
transcripts should be annotated and which ones should not. 
B		Pf3D7_04_v3:92,500..94,699																																																																																																						Pf3D7_0401600	(Riﬁn)	
A		Pf3D7_14_v3:822,000..824,709																																																																	Pf3D7_1419800	(Glutathione	Reductase)	
 
Figure 4.1.  Application of ISRPM/FPKM parameters to Plasmodium RNA-seq datasets 
discriminates significant introns from low abundance variants (from PlasmoDB.org). 
Genome annotation and selected RNA-seq tracks from gametocytes and late trophozoites.  Note 
that blue and red tracks are scaled logarithmically, while tracks shown in semi-transparent over-
lay are linear (note different scales, selected to highlight stage specific expression).  Arrows and 
circles indicate transcript termini.  Note the two translational starts in A (arrowheads), which have 
been confirmed to have different localizations within the strain 3D7 of P. falciparum (Kehr et al. 
2010).  Two tracks display candidate introns (brackets): the ‘filtered’ track is restricted to display 
only those introns that pass the abundance and efficiency criteria described in this dissertation.  
The star in panel B indicates an acceptor splice variant that deletes a single aminoacid from the 
Rifin transcript. 
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Most biologically-significant errors in the current reference annotation for T. gondii 
relate to inaccurate annotation of transcript initiation, often impacting the predicted 
translational start site (Figs. 2.7 & 8), and hence subcellular localization predictions 
(which are particularly important for pathogenic species that secrete factors modifying 
the host response).  These kinds of errors can be addressed by several mechanisms, 
such as implementing known features of transcriptional initiation context (Matrajt et al. 
2004), incorporating evidence from conserved sequences in orthologous genes and 
proteins from other related species as well as evidence from proteomic experiments.  
Other solutions could also be to consider data from promoter binding experiments (Niu, 
Tabari, and Su 2014) as wells as from full length RNA-seq (Sharon et al. 2013) and 
other sequencing technologies that sequence fragments of up to 150kb (Jain et al. 
2016). 
Longer reads will also benefit research and analysis of alternative splice variants, as 
complete or near complete sequenced RNAs would have less sources of error generally 
produced during the assembly of short reads from current Illumina NGS into trans-
cript(s).  In order to estimate the significance of alternative splice variants, phylogenetic 
comparisons aiming to ask if putative variants are conserved in several strains of T. 
gondii or in other closely related species, such as Neospora sp. and Plasmodium sp. 
should be considered.  Examination by multiple sequence alignments of how different 
regions within potential variants change in sequence in their ortholog counterparts 
should provide more evidence towards the functional significance, if any, as well as the 
conservation of these variants among several related species.  Characterization of 
changes in abundance of alternative transcripts across different spliceosomal mutants 
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should provide an extra layer to evidence about the potential biological significance of 
splice variants.  
The existing genome annotation could also benefit from identifying new unanno-
tated transcripts such as lncRNAs.  Our current ability to predict plausible lncRNAs from 
sequencing data is poorly developed, as definition of lncRNA transcripts has proven 
difficult because they do not contain the same sequence features as protein coding 
transcripts.  Developing new gene finders that use machine learning techniques to learn 
sequence features from known T. gondii lncRNAs would be the best approach to charac-
terize lncRNAs, as methods developed for other species have proven not applicable in 
T. gondii since they are specific for the system for which they were developed (Liao et al. 
2011; Fiscon, Paci, and Iannello 2015). 
Transcriptional regulation 
In order to study possible mechanisms of transcriptional regulation, we also carried 
out transcriptional profiling by RNA-seq, including other available transcriptional data to 
encompass sequencing information from all stages of the complex parasite life cycle 
(Table 1).  Steady-state transcript levels highlight important differences, even within the 
intracellular replication cycle, and circumstantial evidence suggests an important role of 
antisense transcription (including lncRNAs) in regulating stage-specific expression.  
Stage-specific expression was previously known is readily distinguished in all major life 
cycle stages by PCA and MDS analysis (cf. Figs. 3.1-3).  As expected, between-stage 
differences were greater than between-strain differences (Fig 3.2), and to our know-
ledge, this report provides the first observation of profiling differences within the 
tachyzoite replicative cycle (Fig 3.4), including differences between intracellular and 
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extracellular parasites, and early and late stage intracellular tachyzoites.  It will be 
interesting to determine the functional significance of these differentially-regulated 
transcripts within the tachyzoite lytic stage.  
Analysis of strand-specific RNA-seq data has identified a previously unappreciated 
diversity of (unannotated) long non-coding RNAs (lncRNAs).  We looked for differential 
expression of sense vs antisense transcripts in tachyzoites (the acutely lytic stage 
causing disease, which is readily cultivated) vs either bradyzoites (the latent cyst stage, 
which is less readily grown in culture), gametocytes (tachyzoites or bradyzoites under-
going sexual differentiation in the epithelium of the cat’s gut) or sporozoites (the result of 
sexual crosses, which is not readily obtained in the lab) to examine elucidate the 
relationship between sense and antisense transcripts.  The function of these transcripts 
is not yet clear, but many overlap the 3’ UTR of coding genes, and display stage-specific 
mutually-exclusive coding vs non-coding transcript expression (cf. Figs. 3.5, 3.6 & 3.7), 
suggesting a possible role in the regulation of stage-specific expression, specially during 
the sexual stages. 
In order to determine if antisense transcripts play a significant role in transcriptional 
regulation during parasite biology, several strategies and experiments could be carried in 
future research.  One would be to map antisense lncRNAs promoters in T. gondii tachy-
zoites using for example a luciferase transient transfection assay.  Other experimental 
option to elucidate the function of antisense transcriptional regulation would be to test 
the hypothesis that antisense lncRNAs regulate expression of sense overlapping mRNA 
transcripts, by manipulating their expression in transgenic parasites. Three experimental 
approaches could be used to test this hypothesis.  One would be using the Ku80 knock-
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out system for targeted homologous recombination in T. gondii to delete the 5’ upstream 
region (and ideally the promoter region) for tachyzoite-specific lncRNAs.  Antisense and 
sense transcript expression will then be assessed by strand-specific qPCR.  A second 
experimental strategy would be to overexpress antisense lncRNAs in tachyzoites from a 
tet-inducible promoter, following antisense and sense transcript expression/repression 
by strand-specific qPCR.  Finally, a third experimental approach could exploit CRISPR 
mutagenesis to specifically change the sequence of strand-specific antisense transcripts 
and or their promoters in tachyzoite parasites and then monitor antisense and sense 
transcript expression/repression by strand-specific qPCR.  These strategies, however, 
would generate fewer insights into a possible biological role of antisense transcripts 
because the most striking regulation appears to be occurring in the sexual stages of the 
parasite, especially sporozoites, where manipulation has proven to be difficult. 
Other interesting projects could be continued from the data generated for this thesis.  
Sequencing experiments also yielded data on host cell responses to parasite infection 
as well as on small non-codingRNAs (sncRNAs) from the parasite and its host cell.  
Analysis of host cell responses to parasite infection should permit identification of co-
regulatory patterns correlating host and pathogen gene expression, such as relation-
ships between metabolic pathways and receptor-ligand interactions, among others.  In 
related work, we also provided Jonathan Wastling’s group at Liverpool with parallel 
samples for quantitative proteomic analysis, and it will be interesting to compare parasite 
and host transcriptomics vs proteomics. 
Mapping of sncRNAs reads to the parasite genome showed that they are most 
abundantly found on repeats and introns of genes (mRNA).  Parasite expressed 
	
83	
	
sncRNAs are of several different sizes, varying from the 21-23nts size that are usually 
observed in humans.  Different classes of sncRNAs, regulated in a tissue and time 
specific manner in plants and animals, are well known to play important roles in mech-
anisms such as defense, development and chromatin regulation (Kim and Sung 2012; 
O’Connell, Rao, and Baltimore 2012).  However the apparent lack of an abundant unified 
size class (>50%) in T. gondii sncRNAs, indicates that the origin and possible function of 
sncRNAs is different from what is known in other organisms. The T. gondii genome 
codes for a Dicer and an Argonaute protein.  The TgDicer protein, in charge of cleaving 
long dsRNA and generating siRNA or miRNA precursors, is composed of a RNA 
helicase domain and two RNase II catalytic domains.  Nevertheless it lacks the 
conserved dsRNA binding domains, DSRM and PAZ, features also seen in the Dicer of 
the single cell Algae, Chlamydomonas reindhartii.  The TgArgonaute protein, displays 
conserved PAZ and PIWI domains, along with RGG amino terminal repeats (3X) which 
have the potential to be methylated, a characteristic shared with metazoan and plant 
Argonautes (Braun et al. 2010).  T. gondii also possesses one representative of a RNA 
dependent RNA polymerase (RdRP) which is implicated in other organisms of amplifying 
sncRNAs from endogenous transcripts (Nishikura 2001).  Modified tachyzoite parasites 
have been generated to contain a KO version of Argonaute, but standard characteriza-
tion experiments don’t seem to show any defect, so it is not clear what function TgArgo-
naute is playing.  To assess the possible function of sncRNA in T. gondii, it would be 
interesting to generate KO sexual parasites lacking each of the representatives possibly 
involved in small ncRNA biogenesis and test if they have any effect in the biogenesis 
and/or stability of small ncRNAs. 
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Human small ncRNAs were on average 23nt long, and mapped to several locations 
throughout the human genome, being most abundant in repetitive regions.  The specific 
size of 23nt agrees with known animal miRs and siRNA sizes (McManus and Sharp 
2002).  Out of 317 human miRs analyzed, there were 164 (51.7%) that were suppressed 
two fold or more during infection with both TgRH and TgME49.  Only 18 (5.7%) of 
human miRs were upregulated two fold or more during infection with these two strains, 
among which we found and confirmed what has been previously reported: upregulation 
of members of the family miR-17 (Zeiner et al. 2010).  Additionally we have also encoun-
tered that human miRs -146a and -155 are also among the upregulated microRNAs.  
These have been reported to mediate a negative feedback loop regulation of the human 
transcription factor NF-κB (Taganov et al. 2006), which during T. gondii infection is 
known to be activated in varying degrees by different strains (Rosowski et al. 2011).  
Examining Toxoplasma-infected human cells, we have now found that the more notable 
impact of parasite infection is a profound suppression of most human miR expression.  
Human miRs appear to be suppressed by infection with T. gondii strains RH and ME49, 
but not VEG and by N. caninum.  It will be interesting to following up on these prelimin-
ary results, as they promise to reveal mechanisms of host-parasite interactions.  
In summary, exploiting multiple RNA-seq datasets, from diverse sources, and inte-
grating this information with other functional genomics data, permits substantial improve-
ment in the annotation of the Toxoplasma gondii genome and transcriptome.  The 
methods described here should be readily incorporated into computational pipelines, and 
are likely to prove useful for other species as well. 
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APPENDIX MATERIALS 
 
The following supplementary materials are available in the supplemented CD: 
 
Additional File 1:  Microsoft Excel .xlsx file containing the following spreadsheets, each 
represented as a separate tab: Data, Stats, Annotated noEvidence (FP), Unannotated 
AltSplicing (FN) and Unannotated NewGenes (FN).  ‘Data’ lists all annotated introns and 
unannotated intron-spanning reads observed at plausible abundance (59,755 rows), 
along with information on chromosomal position & strand, gene mapping & location 
within the gene, annotation status, ISRPM values, FPKM (when mapped to genes), and 
ISRPM/FPKM values, for all 20 high quality strand-specific RNA-seq datasets (see Table 
1).  Additional columns indicate the maximum ISRPM observed for each intron, the 
maximum ISRPM for any alternative overlapping intron, and corresponding FPKM & 
ISRPM/FPKM values.  Appropriate columns from this table were used to generate Figs 
2.4, 2.5, 2.6, 2.12 & 2.13.  The ‘Stats’ tab provides counts and several statistics relating 
to the ‘Data’ tab, including data presented in Table 2.  Other tabs present filtered views 
of ‘Data’ highlighting specific corrections recommended for the reference T. gondii 
genome annotation. 
 
Additional File 2:  PDF file containing supplementary figures S1-S5.  Legends are 
included at the beginning of this file. 
 
Additional File 3:  Excel .xlsx file containing supplementary spreadsheets, presenting 
FPKM values for all 8920 annotated genes, from all 20 high-quality strand-specific 
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studies analyzed in this manuscript (Table 1), in addition to various averaged datasets, 
e.g. all strain ME49 parasites, all 4 hr post-infection samples, etc).  Additional tabs 
present analysis of these data using various transcript abundance cut-offs, as noted, by 
PCA & MDS (see Figs 3.1, 3.2, 3.3 & 3.4 and Table 3), as well as HC (heatmap), AGC, 
etc (see Methods). 
 
Additional File 4:  Excel .xlsx file containing supplementary spreadsheets, presenting 
sense and antisense FPKM values for all 8920 annotated genes, from 20 high-quality 
strand-specific studies analyzed in this thesis (Table 1), plus the ME49 hr 2 sample, in 
addition to various averaged datasets, e.g. all gametocyte samples, and pairwise 
comparisons between samples e.g. the ME49 tachyzoite vs d7 CZ-H3 gametocyte 
comparison (presented in Fig 3.6).  The second tab contains transformations of mini-
mum and maximum FPKM values as indicated in the tab name. 
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